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Abstract
The Effects of the Gut Microbiota on the Host Chromatin Landscape
by
Nicholas Paul Semenkovich
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Genetics and Genomics
Washington University in St. Louis, 2017
Professor Jeffrey I. Gordon, Chair 
The human gut microbiota is home to tens of trillions of microbes belonging to all three domains 
of life. The structure and expressed functions of this community have myriad effects on host 
physiology, metabolism, and immune function. My studies focused on a facet of host-microbial 
interactions and mutualism that has not been explored to a significant degree in part because of the 
absence of suitable tools: namely, if, when, and how the gut microbiota produces durable effects 
on host biology through its impact on the epigenome. To address this area, I turned to gnotobiotic 
mice and developed a variety of experimental, methodological, and computational approaches to 
characterize the chromatin landscape of various host cell populations. I selected small populations 
of T cells likely to be exposed to the gut microbiota and its products, principally TCR αβ+ and TCR 
γδ+ small intestinal intraepithelial lymphocytes (IELs). I also chose to study circulating CD4+ and 
CD8+ T cells, with the advantage that these populations can be isolated from donors without using 
highly invasive techniques. I designed a series of approaches to enrich, isolate, and purify each of 
these cell populations from single animals, and to subsequently compare their chromatin landscape 
within and across mice using a recently described Assay for Transposase-Accessible Chromatin 
with high throughput sequencing (ATAC-seq), focusing on enhancer and super-enhancer loci with-
in the mouse genome. These analyses revealed a conserved set of super-enhancer loci between αβ 
and γδ IELs, including super-enhancers near genes responsible for phospholipid binding and T cell 
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receptor signaling. In comparing C57BL/6J male mice reared under germ-free (GF) conditions to 
age- and sex-matched conventionally raised (CONV-R) mice (i.e., animals that acquired microbes 
from their environment beginning at birth), I was able to directly assess the impact of coloniza-
tion on chromatin ‘state’ in these different purified cell populations and to identify colonization-
dependent effects in IELs on enhancers associated with genes involved in a number of metabolic 
and signaling pathways. I then compared the results to GF mice that had been colonized following 
the end of the weaning period with an intact cecal microbiota from a CONV-R C57BL/6J donor. 
The resulting conventionalized (CONV-D) animals allowed me to identify modifications to host 
chromatin landscape that are ‘induced’ following the suckling-weaning transition and, in doing so, 
ascertain whether there were developmental windows that could constrain the durable effects of 
the microbiota on chromatin accessibility. In doing so, I observed changes in chromatin accessibil-
ity with colonization that may reveal a functional maturation of IEL populations that is related to 
the timing of exposure to the microbiota during postnatal development. My thesis project involved 
development of an elaborate, multi-faceted computational pipeline for the analysis of these novel, 
large datasets, including the prediction and characterization of putative enhancers and super-en-
hancers, proximally associated genes, and metabolic pathways influenced by those elements. As a 
whole, this work defines the impact of gut microbial colonization on host chromatin landscape and 
provides an analytical toolkit for further studies.
1Chapter 1
Introduction
2Introduction
The gut microbiota and host can be thought of as a ‘holobiont,’ where both host and microbes 
coexist and interact in a complex range of relationships, ranging from symbiotic and mutually 
beneficial (e.g., the biosynthesis of vitamins and co-factors) to harmful or parasitic. This spectrum 
of interactions has been present as both host and bacteria have evolved over millennia, and has 
resulted in numerous systems — largely immunologic — that regulate and influence these rela-
tionships. While some of these regulatory systems have been described over the past few decades, 
one possibility that remains largely unexplored is that host-microbiota interactions are influenced 
by epigenetic factors — that is, the microbiota and its products may alter the host chromatin 
landscape to subsequently potentiate and perpetuate phenotypes. Some critical questions in this 
field include: Do periods of nutritional unavailability and dysbiosis potentiate longer-term impacts 
in the host via epigenetic mechanisms? Are host-chromatin modifications durable (does the host 
keep an epigenetic ‘memory’ of prior exposure to a given microbial community configuration or 
configurations)? Is there a critical temporal window of exposure, where microbial signals must 
be received by the host before they are able to alter the chromatin landscape in a permanent way? 
These key questions are what drove my exploration and interest throughout this thesis.
Epigenetic interactions between the gut microbiota and its host
Several studies have presented a range of evidence for epigenetic interactions between the gut 
microbiota and its host. There are a multitude of analytical techniques available to characterize 
the epigenome (reviewed in Winter et al. 2015). In light of their strengths and weaknesses, it is 
important to consider each report in the context of the methods applied.
A number of studies have looked at changes in DNA methylation in host tissues, and its 
association with microbiota composition. Given high input material requirements of many meth-
ylation-based techniques (Tsompana & Buck 2014), some of these studies necessarily focus on 
heterogeneous host cell populations, where a large amount of cellular material is available — but 
mixed input populations can complicate interpretation of results. Some of the earliest studies of 
3microbiota-epigenetic interactions focused on the immune system, using microarray-based assays 
for methylation. Kellermayer et al. (2011), interrogated the methylation patterns of the colonic 
mucosa in wild type C57BL/6 mice, and in a Tlr2(-/-) mouse model (of interest given its asso-
ciations with IBD and intestinal barrier function (Cario 2008)), using a custom microarray. They 
determined that, compared to WT mice, Tlr2(-/-) mice showed significant methylation differences 
around a number of genes associated with inflammatory pathways (e.g., Alanyl Aminopeptidase 
[Anpep], and annexin A8 [Anxa8]); these changes were associated with a decrease in the rela-
tive abundance of Firmicutes and increases in the representation of members of Proteobacteria, 
Bacteroidetes, and Actinobacteria. However, their study was not designed to separate microbiota-
induced changes from the effects of the Tlr2 knockout alone.
In another example of a methylation-based approach, (Kumar et al. 2014) looked at whole 
blood methylation patterns across pregnant women, segregated based on whether their fecal mi-
crobiota appeared to be dominated by Bacteroidetes and Proteobacteria, versus Firmicutes. In 
women whose microbiota harbored Firmicutes as the dominant phylum (as compared to a Bacte-
roidetes/Proteobacteria dominated group), they identified differential methylation patterns around 
genes associated with increased risk for obesity and the metabolic syndrome. Other studies have 
focused on dietary contributions to host methylation, including Schaible et al. 2011, where female 
mice were placed on a methyl-donor diet (a diet supplemented with folic acid, B12, betaine, and 
choline) during pregnancy. The offspring of these conventionally-raised mice were observed to 
have alterations in DNA methylation patterns (associated with a variety of loci, including Ppara), 
an increased susceptibility to dextran sodium sulfate-induced colitis, and structural changes in the 
microbiota (including an increased proportional representation of Clostridia and a decreased rep-
resentation of Lactobacilli); these differences did not last beyond 90 days.
Numerous associational studies have also been performed in humans, highlighting epigen-
etic and microbial factors in a range of (generally gastrointestinal) diseases. Based on observa-
tions that Fusobacterium was detected frequently in biopsies and excised tumors of patients with 
colorectal cancer (Castellarin et al. 2012), Tahara et al. (2014) characterized intestinal methylation 
4differences in patients with colorectal cancer, stratified by the presence of Fusobacterium in tumor 
sections. They discovered that tumors enriched for Fusobacterium had CpG island methylator 
phenotypes (CIMP), and an increase in microsatellite instability.
A small number of recent studies have tried to more directly define links between the 
microbiota and epigenetic changes, leveraging sterile ‘germ free’ (GF) mice while profiling epi-
genetic features. Obata et al. (2014) identified a specific DNA methylation adapter (Uhrf1) that 
was upregulated in intestinal Treg cells upon conventionalization of GF mice. Upon deletion of 
this locus in Tregs hypomethylation was observed in the promoter region of Cdkn1a, resulting 
in cell-cycle arrest and severe colitis. Camp et al. (2014) performed ChIP-seq and RNA-seq on 
intestinal epithelial cells (IECs), in GF and CONV-R mice. Their study determined that transcrip-
tional changes were not associated with changes in ileal or colonic chromatin accessibility within 
epithelial cell populations. Yu et al. (2015) used whole-genome bisulfite sequencing to character-
ize methylation differences in GF versus conventionally raised (CONV-R) C57BL/6J mice. Fo-
cusing on Lgr5+ intestinal stem cells (ISCs), the group identified an increase in ISC methylation 
at CpG islands during the suckling period that were correlated with changes in transcription of 
certain glycosylation genes. They also performed a time-series analysis of GF vs CONV-R mice, 
which identified a reduction in methylation at numerous sites in GF mice and that these alterations 
were correlated with gene expression changes in at least two loci (B4galnt1 and Phospho1). They 
observed a rescue of this phenotype (an increase in methylation and associated changes in gene 
expression) in small cohort of GF mice (n=3) that were subsequently colonized at 25 days of life, 
and sacrificed at 100 days (a 75-day colonization period).
Potential mechanisms by which the gut influences the host epigenome
In part through the studies above, a number of mechanisms have been proposed by which the 
microbiota may influence the host epigenome (Alenghat & Artis 2014). One recurring theme in 
the literature is that elaborated microbial products and metabolites can directly influence the host 
epigenome. These metabolites, their influences, and proposed mechanisms, range from straight-
5forward (e.g., methyl donors that provide methyl groups for epigenetic modifications), to complex 
microbial processing of food components that subsequently signal host cells.
The most fundamental proposed mechanism for gut-host epigenetic signaling is through 
the simple availability of methyl donors. A variety of gut-derived products serve as methyl donors 
or cofactors for base-pair methylation and the remodeling of chromatin, including folate and a 
variety of B vitamins (B2, B6, and B12), methionine, choline, and betaine (Anderson et al. 2012). 
These are all components of one-carbon metabolism pathways that contribute to the availability 
of S-adenosylmethionine (SAM), and transporters for many of these methyl donors are expressed 
within the colonic epithelium (Said et al. 2000; Visentin et al. 2014; Albersen et al. 2013). SAM 
itself is utilized by methyltransferases in the maintenance and establishment of DNA methylation. 
A large body of work has observed associations between dietary intake of these methyl donors and 
host DNA methylation patterns, including the studies described above (reviewed in Anderson et al. 
2012). Notably, the microbiota can also produce or modify some of these methyl donors directly, 
including folate and a variety of B vitamins (Jeffery & O’Toole 2013).
Beyond direct contributions to the methyl donor pool, diet and the microbiota may con-
tribute to more nuanced epigenetic signaling through metabolites, including short chain fatty acids 
(SCFAs). SCFAs are elaborated by commensal bacteria through their anaerobic fermentation of 
plant polysaccharides, and include propionate, acetate, and butyrate. Beyond being used as critical 
energy source by the host (Donohoe et al. 2011), these metabolites can signal through GPCRs, and 
act as histone deacetylase inhibitors (HDACs) (Vinolo et al. 2011). Through these mechanisms, 
commensal bacteria may influence host phenotypes: Alenghat et al. (2013) demonstrated that the 
absence of HDAC3 in IECs resulted in broad dysregulation in gene expression and increased sen-
sitivity in a DSS-induced colitis model, a phenotype that was abrogated in GF mice. Additionally, 
a number of models have identified specific signaling mechanisms with immunologic impacts, for 
example, Arpaia et al. (2013) demonstrated one route through which butyrate enhanced extrathy-
mic differentiation of Tregs.
6Overview of the thesis
Based on this background, I set out to explore the potential contributions of the microbiota to the 
host chromatin landscape, using a mouse model. I chose to analyze this in the most controllable, 
reproducible approach, using sterile (‘germ-free’) mice and comparing them to their convention-
ally raised (CONV-R) counterparts. To better understand potential ‘critical window’ effects, I also 
included a ‘conventionalized’ arm, consisting of mice that were raised germ-free, and then sub-
sequently colonized (‘conventionalized’, CONV-D) following the three-week suckling-weaning 
transition. 
I turned to a nascent technology when this thesis began to profile chromatin accessibil-
ity across multiple cell populations in these mice. ATAC-seq (Assay for Transposase-Accessible 
Chromatin using Sequencing (Buenrostro et al. 2013)) is a transposase-based technique similar to 
DNAse-seq. In ATAC-seq, the Tn5 transposase is pre-loaded with Illumina sequencing adapters 
and incubated with isolated nuclei. The transposase can then insert these sequencing adapters into 
regions of chromatin that are ‘open’ (areas of uncondensed, accessible chromatin). The resulting 
fragments of DNA can be amplified and sequenced, which reveals a genome-wide map of the open 
chromatin landscape (see Figure 1).
I focused on cell lineages potentially exposed to the microbiota and its products (and cells 
that could drive responses to microbial colonization) and selected four cell populations that met 
those criteria: circulating peripheral lymphocytes (both CD4+ and CD8+ T-cells), and intestinal 
intraepithelial lymphocytes (TCR αβ+ and TCR γδ+ T-cells).
I developed a protocol to rapidly and simultaneously isolate these populations from single 
mice, to ensure I could generate data without pooling samples across mice. Within these cell popu-
lations, I focused my analyses on enhancers — regions of chromatin that can drive the expression 
of genes (including non-classical elements like lncRNAs) via the recruitment of activating factors, 
and characterized the enhancer landscape of these cells for both colonization dependent and inde-
pendent features.
7The computational challenges I faced were great: assuming ATAC-seq data could be gen-
erated, no pipeline existed for its analysis and processing. Additionally, existing pipelines for re-
lated types of data (e.g., DNAse-seq) tended to be fragile and poorly documented, which largely 
precluded their adaptation to ATAC-seq data. Additionally, the computational resources for super-
enhancer prediction were designed for different data types (ChIP-seq) and differential accessibility 
analyses tended to be performed on an ad-hoc basis. I developed a flexible, portable, and docu-
mented computational pipeline for the analysis of ATAC-seq data, including its pre-processing, 
enhancer and super-enhancer characterization, and differential accessibility prediction, with the 
goal of establishing a permanent toolkit for other researchers, as the use of ATAC-seq and DNAse-
seq grows.
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Figure legend
Figure 1. A broad overview of an ATAC-seq analysis is shown, where cells are first isolated and 
nuclei are prepared. Then, nuclei are incubated with the Tn5 transposase, and subsequently se-
quenced. Next, areas of high signal compared to background (‘peaks’) are called, and aggregated 
across samples, followed by the identification of nearby genomic features. The transposase graphic 
is adapted from Buenrostro et al. 2013.
11
Call peaks
Aggregate signal
across samples
Identify nearby
genomic features
Atac-seq 
transposition
Sequencing
Cell isolation
Figure
Figure 1.
12
Chapter 2
The impact of the gut microbiota on enhancer accessibility 
in gut intraepithelial lymphocytes
13
The impact of the gut microbiota on enhancer accessibility 
in gut intraepithelial lymphocytes
Nicholas P. Semenkovich1,2, Joseph D. Planer1,2, Philip P. Ahern1,2, Nicholas W. Griffin1,2, Charles 
Y. Lin3, Jeffrey I. Gordon1,2*
1Center for Genome Sciences and Systems Biology, 2Center for Gut Microbiome and Nutrition 
Research, Washington University School of Medicine, St. Louis, MO 63110, USA
3Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, 
USA
*To whom correspondence should be addressed: e-mail jgordon@wustl.edu
14
Abstract
The gut microbiota impacts many aspects of host biology including immune function. One hy-
pothesis is that microbial communities induce epigenetic changes with accompanying alterations 
in chromatin accessibility, providing a mechanism that allows a community to have sustained host 
effects even in the face of its structural or functional variation. We used Assay for Transposase-
Accessible Chromatin with high-throughput sequencing (ATAC-seq) to define chromatin acces-
sibility in predicted enhancer regions of intestinal αβ+ and γδ+ intraepithelial lymphocytes puri-
fied from germ-free mice, their conventionally raised (CONV-R) counterparts, and mice reared 
germ free and then colonized with CONV-R gut microbiota at the end of the suckling–weaning 
transition. Characterizing genes adjacent to traditional enhancers and super-enhancers revealed 
signaling networks, metabolic pathways, and enhancer-associated transcription factors affected by 
the microbiota. Our results support the notion that epigenetic modifications help define microbial 
community-affiliated functional features of host immune cell lineages.
Significance
Comparing germ-free mice with those colonized at birth or later provides a way to determine 
how gut microbial community exposure affects the chromatin landscape of cells along the gut or 
at remote sites, ascertain how alterations in chromatin accessibility are correlated with functional 
features of different lineages, and determine whether there is a critical window of exposure when 
microbial signals must be received to alter the landscape durably. Genome-wide analysis of chro-
matin accessibility in intraepithelial lymphocytes and circulating T cells purified from gnotobiotic 
mice revealed enhancers and flanking genes involved in signaling and metabolic pathways that 
are sensitive to colonization status. Colonization does not fundamentally alter lineage-specific 
cis-regulatory landscapes but induces quantitative changes in the accessibility of preestablished 
enhancer elements.
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Human gut microbial communities interact with their hosts in ways that affect physiology, 
metabolism, and immune function. The underlying mechanisms are subjects of intense investiga-
tion. One hypothesis is that the gut microbiota induces epigenetic changes in host cells, altering 
chromatin accessibility and the subsequent poising of genes for expression. Chromatin modifica-
tions have the potential to outlast a given microbiota configuration and endow the host with a 
“memory” of microbial exposure (1). This hypothesis has been investigated in a limited number of 
studies. DNase-seq applied to intestinal epithelial cells identified few differences in the chromatin 
landscape between germ-free (GF) and conventionally raised (CONVR) mice (2). Another study, 
using bisulfite sequencing, analyzed pooled populations of Lgr5+ intestinal stem cells and found 
colonization dependent methylation of numerous CpG loci (3). More recently, iChIP-IVT (Index-
ing first Chromatin Immunoprecipitation-In Vitro Transcription) was used to assess chromatin 
state in all three subsets of innate lymphoid cells harvested from CONV-R and antibiotic-treated 
mice. The results identified thousands of H3K4me2 regions that were sensitive to antibiotic treat-
ment, with a number of these regions losing their specificity for different innate lymphoid cell 
subsets (4).
In the present study, we use ATAC-seq (Assay for Transposase Accessible Chromatin 
with high-throughput sequencing) to examine this hypothesis. ATAC-seq uses a Tn5 transposase 
preloaded with sequencing adaptors; this approach enables efficient in vitro transposition of the 
adaptors into regions of accessible (“open”) chromatin (5) which correlate with primed or active 
enhancers. ATAC-seq is agnostic to the type of epigenetic modification and, importantly, allows 
analyses to be performed on small populations of cells. Our focus on the effects of the gut micro-
biota on enhancers was based on the supposition that identifying these regions, their neighboring 
genes, and the signaling and metabolic pathways to which these genes belong would provide 
mechanistic insights about how the gut microbial community influences the biological properties 
of immune cell populations. We targeted two populations that are in intimate association with the 
gut microbiota and its products: T-cell receptor (TCR) αβ+ and TCR γδ+ intraepithelial lympho-
cytes (IELs). IELs participate in immune surveillance, immune tolerance, wound repair, mainte-
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nance of gut barrier function, and protection from infectious agents (6). Given these roles, it is 
not surprising that considerable attention has been directed to how the microbiota shapes the IEL 
compartment (7, 8), although the relationship between the microbiota and IELs is less well char-
acterized than other components of the immune system. We also examined peripheral CD4+ and 
CD8+ T cells, reasoning that they may have transient exposures to products of the gut microbiota, 
can be sampled more readily than IELs, and would allow us to delineate extraintestinal epigenetic 
effects of the microbiota.
Results
Experimental Design and Approach to Analysis.
Three groups of 8- to 10-wk-old male C57BL/6 mice were studied: a group reared under sterile 
conditions (GF mice), a CONV-R group exposed to microbes present in their environment from 
the time of birth, and a group initially maintained GF until the suckling–weaning transition at 3 wk 
of age and then colonized with a cecal microbiota from a CONV-R donor (conventionalized mice, 
CONV-D) (n = 8 mice per treatment group). The relatively low numbers of cells required to per-
form ATAC-seq allowed us to study different cell populations from single animals without needing 
to pool samples (Fig. S1A) and to identify predicted enhancers within a given cell lineage, includ-
ing those whose accessibility is altered by microbial exposure during postnatal development.
To analyze the large datasets generated (Dataset S1), we developed an open-source, Py-
thon-based computational pipeline named RIESLING (Rapid Identification of Enhancers Linked 
to Nearby Genes). RIESLING was inspired by the ROSE (Rank Ordering of Super-Enhancers) 
software designed for ChIP-seq (9, 10) and developed as a toolkit to standardize analysis of data-
sets generated from ATAC-seq. RIESLING is designed to enable de novo prediction of putative 
enhancers and characterization of their differential accessibility (Fig. S2). Briefly, sequencing data 
generated following ATAC-seq transposition are used to call “peaks” (open regions of chromatin 
with a read density statistically higher than background) identified using a Poisson model adapted 
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from standard approaches used for ChIP-seq and DNase-seq analyses. To predict putative enhanc-
ers, peaks and their underlying raw read depth are aggregated based on one of three approaches: (i) 
unstitched (peaks and their underlying raw read depth); (ii) fixed stitching, in which peaks within 
a certain distance of each other [typically a 12.5-kb window (10)] are merged together to represent 
one broad region of interest; or (iii) dynamic stitching, in which a window is slowly increased 
from 0 kb (unstitched) to a maximum of 15 kb, in adjustable increments of 500 bp, and the number 
of enhancer clusters identified per window is recorded. The rate of growth (the first derivative) 
of this growing window is computed, and the point at which the rate of growth of called enhanc-
ers decreases (the inflection point) is used to merge nearby peaks together. (See SI Materials and 
Methods for further discussion of the rationale for using these three approaches in various facets 
of our analyses).
The Super-Enhancer Landscapes of IELs and Circulating T Cells, Independent of 
Colonization Status.
We identified putative enhancers shared by the two types of purified IEL populations (αβ+ and γδ+ 
T cells) and those shared by the two types of purified peripheral lymphocyte populations (CD4+ 
and CD8+ T cells), independent of colonization status (GF ∪ CONV-R ∪ CONV-D; Fig. S1B). 
Data generated from these purified cell populations were highly reproducible (Fig. S1C). The 
different enhancer populations were reflected in a hierarchical clustering that clearly stratified by 
cell type (Fig. S3A). We divided these putative enhancers into two groups: a set of “traditional” 
enhancers, and a subpopulation of super-enhancers. Super-enhancers are a subclass of enhanc-
ers that are stronger (more occupied by transcriptional activators) and can span longer regions of 
DNA than traditional enhancers (9, 10). Super-enhancers can drive cell lineagespecific functions 
and play critical roles in disease pathogenesis (11, 12). We identified super-enhancers by first com-
bining adjacent peaks within a 12.5-kb window (the fixed stitching approach described above), 
ranking and graphing these merged enhancers by their normalized read depth (ATAC-seq signal), 
and discriminating traditional enhancers from super-enhancers by determining where the slope of 
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a tangent line fitted to their graph reached one (10). The resulting graph fit an exponential curve 
in which the largest ATAC-seq signal occurred at a small minority of enhancers (Fig. S3B and 
Dataset S2).
Super-enhancers, although comprising <5% of the aggregate IEL enhancer population 
(4.4% in TCR αβ+ IELs and 4.9% in TCR γδ+ IELs), accounted for a disproportionate share of the 
aggregate ATAC-seq signal (35%) compared with the traditional enhancer group; super-enhancers 
also spanned broader regions of the genome than did traditional enhancers [29,447 ± 440 vs. 3,988 
± 31 bp (mean ± SEM)]. These patterns fit well with other studies, which show similar distributions 
of signal and enhancer width when applying ATAC-seq and complementary techniques, including 
p300 and Mediator ChIP-seq, in different tissues (9, 12, 13). The colonization-independent super-
enhancer populations in TCR αβ+ and TCR γδ+ IELs were highly similar, with a Jaccard similarity 
index of 83% (Fig. S3A). The top-ranked super-enhancer in both IEL populations is adjacent to 
Prkch (Fig. S3B), a nonclassical Ca2+-insensitive η-type PKC that promotes T-cell activation and 
cytoskeletal polarization (14, 15).
Applying the same analytic approach to peripheral circulating T cells revealed that super-
enhancers comprised 5.7% of the population but 37.7% of the aggregate ATAC-seq signal [values 
comparable to those reported in mice and humans (9, 12, 13, 16)]. The super-enhancer associated 
with Bach2 (basic leucine zipper transcription factor 2) produced the top-ranked ATAC-seq signal 
in CD4+ T cells (Fig. S3 C and D and Dataset S2). This finding was notable, given a previous re-
port that used p300 ChIP-seq to identify Bach2 as the strongest super-enhancer in CD4+ T cells, 
and as a critical negative regulator of pathogenic T-cell effector differentiation and as a positive 
regulator of regulatory T-cell induction (12, 17).
We performed a network analysis of genes located in the proximity of the top 250 super-
enhancers (ranked by ATAC-seq signal) from the combined population of TCR αβ+ and TCR 
γδ+ IELs, independent of colonization status, using GeNets (SI Materials and Methods). GeNets 
defines “communities” as sets of genes with a high degree of connectivity based on a random for-
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est classifier trained on datasets of established protein–protein interactions. This network analysis 
clustered super-enhancer–associated genes into eight distinct communities that display functions 
that are lineage-defining components of IELs (e.g., TCR signaling; see Dataset S3 for a complete 
list of components and their assigned functions). GeNets also identified significant connections 
among these eight communities (Fig. S4).
Contrasting the Chromatin Landscapes of TCR αβ+ vs. TCR γδ+ IELs, Independent of 
Colonization Status.
We applied a negative-binomial model to the dataset of enhancers described above to identify 
lineage-specific features of the TCR αβ+ and TCR γδ+ chromatin landscapes, independent of colo-
nization status. We were wary of applying this model only to the collection of peaks stitched within 
the 12.5-kb window initially applied to the datasets: Although appropriate for defining strong 
super-enhancers, this fixed window could, potentially, drown out signals from differentially acces-
sible but narrower enhancer regions. Understanding that the width of enhancers can vary across 
different cell types and tissues, we used the dynamic stitching approach to merge peaks, with the 
goal of adapting to variable enhancer widths (Fig. S5A). Applying a binomial model to these dy-
namically stitched peaks yielded 4,704 predicted enhancers demonstrating differential accessibil-
ity (13.2% of all dynamically stitched IEL enhancers at P < 0.05 by Benjamini– Hochberg-adjusted 
Wald test). Filtering to a more stringent cutoff (P < 5 × 10−5 by Benjamini–Hochberg-adjusted 
Wald test) yielded 598 predicted enhancers with increased accessibility in TCR αβ+ compared 
with TCR γδ+ IELs and 295 with increased accessibility in TCR γδ+ vs. TCR αβ+ IELs (Fig. S5B). 
(For all differentially accessible enhancers observed at P < 0.05, see Dataset S4 A and B. For an 
analysis in peripheral T cells, see Dataset S4 C and D).
We performed a pathway analysis on the collection of statistically significant enhancers 
using GREAT (Genomic Regions Enrichment of Annotations Tool) (18), first focusing on regions 
with increased accessibility in the TCR αβ+ IEL population and comparing them to the set of all 
enhancers in both IEL lineages independent of colonization status. We used GREAT because it can 
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consider multiple genes in proximity to a given enhancer when calculating pathway enrichment 
(as opposed to a GeNets-based analysis, which incorporates only the most proximal gene). The 
results revealed significant enrichment (P < 0.05; hypergeometric test) of enhancer-adjacent genes 
belonging to numerous pathways in the MSigDB (Molecular Signatures Database) encompassing 
Reactome, KEGG (Kyoto Encyclopedia of Genes and Genomes), other metabolic databases, and 
GO (Gene Ontology). These pathways are rank ordered based on their statistical significance in 
Dataset S5A (see SI Results for further discussion).
Chromatin Landscape in TCR αβ+ IELs from CONV-R vs. GF Mice.
Comparing the TCR αβ+ IEL chromatin landscape in CONV-R vs. GF animals using our dynamic 
stitching approach and binomial model yielded 7,137 predicted enhancers with colonization-asso-
ciated differences in their accessibility (P < 0.05, Benjamini–Hochberg-adjusted Wald test) with 
1,362 surviving more stringent filtering (P < 5 × 10−5 ). Of these, 497 were significantly more ac-
cessible in TCR αβ+ IELs purified from CONV-R mice than in TCR αβ+ IELs from GF animals, 
and 865 enhancers met this more stringent cutoff for increased accessibility in GF animals (Fig. S5 
C and E and Dataset S8A). Fig. 1A shows that IEL enhancers cluster first by colonization history 
and then by cell type, in contrast to circulating peripheral T cells in which cell type has a larger 
discriminatory effect.
We used GeNets to identify potential interactions between genes located near colonization-
associated enhancers. The resulting GeNets communities were enriched for (i) members of the 
PDGF signaling pathway whose associated enhancers were more accessible in TCR αβ+ IELs 
from GF mice (community members Grb10, Pik3cb, Pik3r2, Ptpn11, and Ptprj; see Dataset S9A) 
and (ii) members of JAK-STAT [community members Cblb (Cbl proto-oncogene B), Il12rb2 (IL-
12 receptor β2), Il23r (IL-23 receptor), Il7r (IL-7 receptor), and Prlr (Prolactin receptor)] and TCR 
(community members Cblb, Nck2, and Prkcq) signaling, and leukocyte transendothelial migration 
[Cxcr4 (C-X-C chemokine receptor type 4), Itga4 (Integrin subunit alpha 4), and Ptk2 (protein 
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tyrosine kinase 2)] pathways whose associated enhancers were more accessible in CONV-R TCR 
αβ+ IELs (Fig. 1B and Dataset S9B).
A GREAT-based analysis of all enhancers with statistically significant (P < 0.05) increased 
accessibility in CONV-R vs. GF TCR αβ+ IELs disclosed significant overrepresentation of path-
ways involved in bile acid metabolism, propionate metabolism, and sulfur amino acid metabolism 
(Dataset S10A). Members of the microbiota direct a complex set of metabolic transformations of 
bile acids (19) which can influence intestinal inflammation through multiple mechanisms. Propio-
nate, a product of microbial fermentation of dietary glycans, is a histone-deacetylase inhibitor (20) 
and has immunomodulatory effects in the gut (21). Sulfur-containing amino acids are coupled to 
methyl donor availability via their interconversion to S-adenosylmethionine. Moreover, gut in-
flammation induces elaboration of homocysteine from monocytes in the lamina propria; increased 
levels of this amino acid are associated with inflammatory bowel diseases (22).
Several genes in the GO “Regulation of lymphocyte activation” pathway with well-de-
scribed roles in the accumulation of IELs were associated with enhancers having greater chromatin 
accessibility following colonization. These include ahr, encoding the aryl hydrocarbon receptor 
(AhR), which controls accumulation of CD8αα+ TCRβ+ IELs (23); id2, which is required for ac-
cumulation of CD8αβ+ IELs (24); il15ra (IL15 receptor α), which encodes a component of the 
IL-15 receptor; and il7r, which specifies a component of the IL-7 receptor. IL-15 and IL-7 are 
important cytokines controlling the accumulation and function of CD8αα+ IELs (25– 28). Ad-
ditionally, members of two pathways, KEGG “Cell adhesion molecules” (35 genes) and KEGG 
“ECM–receptor interaction” (25 genes), were also associated with enhancers exhibiting increased 
accessibility in CONV-R compared to GF TCR αβ+ IELs (Dataset S10A); changes in chromatin 
state affecting enhancers positioned next to genes in these pathways may reflect broad changes in 
TCR αβ+ interactions with the intestinal epithelium upon colonization.
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Chromatin Landscape in TCR γδ+ IELs from CONV-R vs. GF Mice.
We identified 4,579 differentially accessible enhancers in TCR γδ+ IELs recovered from CONV-R 
and from GF animals (P < 0.05, Benjamini–Hochberg-adjusted Wald test). Filtering these datasets 
to P < 5 × 10−5 yielded 165 putative enhancers with significantly increased accessibility and 511 
with significantly decreased accessibility (Fig. S5D and Dataset S8B). GeNets predicted a number 
of communities of interacting genes positioned near topranked colonization-responsive enhanc-
ers, including genes involved in TGF-β receptor signaling and adherens junction pathways; their 
associated enhancers exhibited increased accessibility in CONV-R animals (Dataset S9 C and D).
GREAT-based analysis using the entire collection of statistically significantly enhancers 
with colonization-associated increases in their accessibility disclosed a significant enrichment of 
genes in KEGG “Cell adhesion molecules” and “ECM–receptor rinteractions” pathways (Dataset 
S10D). A similar enrichment of these two pathways was also observed in TCR αβ+ IELs (Dataset 
S10A) and operationally defines a shared response of these two IEL lineages to the presence of a 
gut microbiota. Enhancers neighboring several genes in GO categories involved in leukocyte and 
lymphocyte activation and cytokine interactions also exhibited significant increases in accessibil-
ity with colonization in TCR γδ+ IELs (Dataset S10D); these genes include Cd28, Cxcr4, Il15ra, 
Il2, Il10, Cd40lg, and Ccr7, some of which are associated with the activation of T cells and have 
been implicated in shaping the IEL compartment. As noted above, IL-15 responsiveness has been 
shown to be key for the accumulation of CD8αα+ TCRβ+ cells and also for TCR γδ+ cells (25–28).
ion of cytokine production” were associated with enhancers with decreased chromatin ac-
cessibility in TCR γδ+ IELs from CONV-R compared to TCR γδ+ IELs from GF mice; they 
include tigit, a cell-intrinsic (29) and cell-extrinsic (30) inhibitor of effector T-cell function, Il10, 
which encodes an anti-inflammatory cytokine (31), and furin, which regulates levels of effector 
T-cell activation (32). The reduced accessibility of enhancers associated with these genes may re-
flect a homeostatic response to the increased activation of these cells upon exposure to microbial 
stimuli that is designed to maintain the delicate balance between pathogenic and protective immu-
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nity in the intestine. The top-ranked KEGG pathways composed of genes proximal to enhancers 
that manifest significant decreases in their accessibility in CONV-R TCR γδ+ IELs as compared 
with GF TCR γδ+ IELs are presented in Dataset S10E (e.g., 23 genes involved in KEGG “Inositol 
phosphate metabolism”).
Comparing CD4+ and CD8+ T cells isolated from the peripheral circulation of GF and 
CONV-R mice revealed markedly fewer differentially accessible enhancers than in the IEL popu-
lations (n = 35 and 26 in the CD4+ and CD8+ populations, respectively; P < 0.05 Benjamini–
Hochberg-adjusted Wald test; Dataset S8 C and D). Five enhancer-associated genes (Cblb, Ica1l, 
Lrrc8c, Mid1, and Nme7) were shared between the two T-cell populations. All demonstrated in-
creased accessibility in both lineages in CONV-R compared with GF mice. Many of the differ-
entially accessible peripheral T-cell enhancers were also responsive to colonization in the IEL 
lineages (31% of CD4+ and 46% of CD8+ T-cell enhancers, respectively; compare Dataset S8 A 
and B with Dataset S8 C and D).
Analysis of Enhancers in IELs Purified from CONV-D Mice.
We expanded our analyses to the group of CONV-D mice that had been reared under GF condi-
tions during the first three postnatal weeks and then were colonized with the cecal microbiota of 
an 8-wk-old C57BL/6J CONV-R animal and were killed 5 wk later (see Fig. S6 for the results 
of a bacterial 16S rRNA-based analysis of fecal samples collected at the time mice were killed). 
We binned enhancers based on differences in their accessibility in IELs recovered from CONV-D 
mice compared with IELs recovered from GF mice and in IELs recovered from CONV-D mice 
compared with IELs recovered from CONV-R mice. A set of microbiota-responsive enhancers was 
identified; these were defined as regions in CONV-D mice whose accessibility was significantly 
different compared with regions in GF mice but was not significantly different from regions in 
CONV-R animals.
The top-ranked microbiota-responsive enhancers in TCR αβ+ IELs (n = 172) were located 
in the neighborhood of genes with broad roles in transcriptional regulation and cell growth, in-
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cluding Tshz1, Celf2, and Nav2 (Dataset S11A). Given the limited size of the dataset of these en-
hancers, we applied an alternative approach to identify pathways whose genes are associated with 
microbiota-responsive enhancers. Ingenuity Pathway Analysis (IPA) (SI Materials and Methods) 
revealed that the top-ranked pathway in TCR αβ+ IELs is involved in the late stages of heparan 
sulfate synthesis. In the case of TCR γδ+ IELs, the top-ranked pathways associated with enhancers 
classified as microbiota-responsive (n = 141) were linked to sphingosine-1-phosphate (S1P) and 
ceramide signaling (Dataset S11B). Enhancers located near S1pr1, S1pr2, and S1pr3 contributed 
to these enrichments. One role of S1P is to direct the trafficking of IELs from the thymus to the in-
testine; global hematopoietic deficiency of S1pr1 reduces the ability of TCR γδ+ cells to populate 
the small intestine (33). The representation of these pathways among the microbiota-responsive 
group of enhancers may reflect a component of the codevelopment of the functional state of TCR 
γδ+ IELs and the gut microbial community during an important malleable stage of their relation-
ship.
Transcription Factor Regulatory Circuitry.
Understanding that the accessibility of cis-regulatory enhancer elements is mediated by the recruit-
ment of transcription factors (TFs) and that TFs and enhancers interact in complex feedback loops, 
we performed a de novo reconstruction of TF regulatory circuitry (SI Materials and Methods) 
(34). In any cell type, a small number of the ∼500 expressed TFs critically define cell identity; 
these master TFs are often associated with super-enhancer elements (35). To investigate the ef-
fects of the gut microbiota on the TF circuitry regulating cell identity, we modeled TF–enhancer 
interactions (TFi ) for all TFs associated with dynamically stitched super-enhancers. For each TFi 
, we computed the inward connectivity (“IN degree”) to determine how the TFi is regulated by 
itself and by other TFs at its own enhancer(s). We then computed the outward connectivity (“OUT 
degree”) to quantify how a TFi regulates enhancers of genes encoding other TFs (Fig. 2A). We 
predicted enriched TF binding sites within ATAC-seq–accessible regions for all super-enhancers 
located proximal to TFs in TCR αβ+ and TCR γδ+ IELs from GF and CONV-R mice and then 
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computed the IN and OUT degrees for these super-enhancer–associated TFs. Super-enhancer– 
associated TFs were included in subsequent analyses if their unit-normalized total degree (IN + 
OUT) was greater than 0.75, indicating that the TF is in the top quartile of regulatory influence. 
For each IEL population, the interactions of all super-enhancer–associated TFs with a normalized 
total degree >0.75 are shown in Fig. 2B.
There was a significant concordance for TF regulatory connectivity across IELs, indepen-
dent of colonization status, at 24 TF binding-site motifs (Dataset S12). Both TCR αβ+ and γδ+ IELs 
were enriched for a number of TF motifs, including ETS1/ETS2- binding sites. The ETS family 
plays a crucial role in T-cell development and can induce chromatin remodeling during early T-cell 
differentiation (36). There was also strong enrichment for RUNX1 and RUNX3; members of this 
family of TFs have been identified as regulators of critical TCR αβ+ and TCR γδ+ pathways (37, 
38). A recent assessment of chromatin state in innate lymphoid cells also demonstrated that highly 
active enhancers show enrichment for ETS and RUNX motifs, suggesting potential commonality 
in developmental and functional pathways within IEL populations of the small intestine (39). Ahr, 
encoding the aryl hydrocarbon receptor, also was found to have high regulatory connectivity in 
both GF and CONV-R groups. This observation aligns well with its defined roles in TCR γδ+ cells 
and in CD8αα+ TCRβ+ accumulation, and with our observation that this receptor is colonization-
responsive in TCR αβ+ IELs (23).
We also identified a regulatory network of TF motifs that were sensitive to colonization 
status. We limited our comparisons to GFvs. CONV-R IELs because a much more limited set of 
differentially accessible enhancers was identified in CONV-D IELs after applying our high-strin-
gency cutoff. Ten TF binding-site motifs exhibited a high total degree of regulatory connectivity 
in both TCR αβ+ and TCR γδ+ IELs isolated from GF mice compared with those isolated from 
CONV-R mice (Fig. 2C and Dataset S12). They included the TFs IRF1 and STAT3, which have 
been identified as critical regulators of IEL maturation and the antiapoptotic activity of IL-15 in 
IELs (40). Although the multiple STAT TFs identified in the circuitry share similar binding motifs, 
and thus similar OUT degrees, we are able to infer differences in their regulation by examining 
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their IN degree, which predicts how the genes encoding the TFs themselves are regulated. Addi-
tionally, for the Stat3 gene, there is an increase in enhancer accessibility in TCR αβ+ IELs from 
GF mice compared with TCR αβ+ IELs from CONV-R mice that is not present for Stat1 (Fig. S7). 
The Stat3 enhancer contains large numbers of predicted binding sites for the JUN/FOS and MAFK 
bZIP TFs that are not present in the Stat1 gene (Fig. S7). Taken together, these data suggest an 
increase in the regulatory activity of Stat3 in IELs purified from GF mice compared with those 
from CONV-R animals.
In the reciprocal comparison, three TF binding-site motifs manifested a high degree of 
regulatory connectivity in TCR αβ+ and TCR γδ+ IELs recovered from CONV-R mice compared 
with those recovered from GF animals: GATA3, a critical regulator of T-cell function and master 
TF for Th2 helper cells (41); KLF3, which has broad regulatory roles, including intestinal IgA 
production; and REL, which plays a key role in driving both Th1 (42) and Th17 (43, 44) responses 
to pathogens (Dataset S12 C and D). These observations suggest a microbiota-regulated role for 
these TFs in the establishment and maturation of these IEL lineages.
Discussion
The location and cellular features of IELs are well described. However, the molecular mecha-
nisms underlying their capacity to exert a rapid and diverse set of effector functions in response to 
stimulation have been largely undefined. One key stimulus occurs during colonization of the gut 
with a microbiota. Here, we used ATAC-seq and the RIESLING suite of software tools we devel-
oped to conduct a genome-wide search for enhancers and pathways enriched in genes adjacent to 
these enhancers. Our results demonstrate that this approach can clearly distinguish and classify 
cis-regulatory landscapes of distinct immune lineages. We find that gut colonization status does 
not fundamentally alter lineage-specific cis-regulatory landscapes but rather induces quantitative 
changes in the accessibility of these preestablished enhancer elements (Fig. S5E). Our findings dif-
fer from a previous DNase-seq study in which the authors concluded that the transcriptional state 
was modified by colonization with a gut microbiota from a specified pathogen-free mouse donor in 
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a manner that appeared to be independent of chromatin remodeling (2). That study used a hetero-
geneous population of intestinal epithelial cells. One possible explanation for the differences in our 
conclusions is that signals from enhancers with differential accessibility may be drowned out in a 
highly heterogeneous population of starting cells. We were able to identify quantitative differences 
in chromatin accessibility in purified cell lineages using ATAC-seq, which requires much smaller 
numbers of cells than DNase-seq. Our findings also are consistent with the quantitative changes 
observed in a recently reported iChIPIVT analysis of innate lymphoid cells harvested from CONV-
R animals that had or had not been treated with antibiotics (see the Introduction and ref. 4).
It is tempting to speculate that gut epithelial cell lineages that are in direct contact with 
the microbiota are poised to exploit a preexisting chromatin landscape in ways that allow them to 
respond rapidly to microbial stimulation. Although increases in chromatin accessibility correlate 
with transcriptional activity, these measurements are limited in their ability to characterize more 
complex modulations of the chromatin state. For instance, enhancers can be poised or active (45), 
and the recruitment of chromatin regulators at preexisting accessible sites can dramatically modu-
late transcriptional responses (46–48). Nonresponsive enhancers, which fail to exhibit alterations 
in chromatin accessibility after delayed exposure to a microbiota, could reflect (i) the existence 
of a critical developmental window beyond which chromatin modification is not possible or is 
unlikely; (ii) the need for a minimal length of time of microbial exposure, irrespective of when the 
microbiota is first introduced, that was not satisfied under our experimental conditions (5 wk of 
exposure starting at the end of postnatal week 3); or (iii) differences in the structural and functional 
configuration of the microbiota that we observed between CONV-R and CONV-D animals.
Our results provide an estimation of the magnitude of the gut microbiota’s influence on 
the epigenetic state of IELs and define the enhancers and pathways impacted by colonization. 
Future efforts to understand how the functional epigenetic states of IELs are modified by specific 
members of the gut microbiota, the nature of the diet being consumed, and the period in postnatal 
development when these cells first encounter gut microbes will be important to develop a mecha-
nistic understanding of how these interactions contribute to protective immunity. These questions 
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are relevant not only to normal host development but also to disorders in which various facets of 
development are impaired, including in children with undernutrition who have disrupted matura-
tion of their gut microbiota (49, 50).
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Materials and methods
Mouse experiments were performed using protocols approved by the Washington University Ani-
mal Studies Committee. A detailed description of protocols used for (i) gnotobiotic animal hus-
bandry, (ii) 16S rRNA-based characterization of bacterial taxa present in the fecal microbiota of 
CONV-R and CONV-D mice, (iii) purification of small intestinal IELs and circulating CD4/CD8+ 
T cells, and (iv) ATAC-seq (including transposition and sequencing protocols; the architecture of 
the RIESLING computational pipeline; the approach for identifying enhancers that exhibit sig-
nificant differences in their accessibility in the different immune cell lineages as a function of 
colonization status; data normalization; pathway analyses; and characterization of TF regulatory 
circuitry) is provided in SI Materials and Methods.
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Figure legends
Fig. 1.
The effects of colonization on enhancer populations in IELs. (A) Unsupervised clustering of dy-
namically stitched enhancers identified in all four immune cell populations purified from GF, 
CONV-R, and CONV-D mice demonstrates that these enhancers not only stratify by cell type but 
also stratify TCR αβ+ and TCR γδ+ IEL lineages based on their history of microbial exposure. The 
areas boxed in red show that IELs from GF mice or from CONV-D mice cluster separately from 
IELs recovered from CONV-R mice exposed to microbes beginning at birth. Jaccard distance met-
ric scores between enhancer regions from a given cell type are shown in blue shading where a val-
ue of 1.0 reflects complete overlap. Clustering was performed on the largest dynamically stitched 
enhancers using the super-enhancer cutoffs described in the text. (B) Heatmap demonstrating the 
ATAC-seq signal from components of the “JAK-STAT,” and “leukocyte transendothelial migra-
tion” signaling pathways whose enhancers demonstrate increased accessibility in CONV-R TCR 
αβ+ IELs. These members were identified as overrepresented in a GeNets-based analysis (Dataset 
S9B).
Fig. 2.
Analysis of colonization-associated TF circuitry. (A) Overview of IN/OUT degree. In this ex-
ample, the IN degree is the number of TFs (TF-A, TF-B, and TF-C) that regulate the expression of 
a gene encoding a TF (TF-A). The OUT degree is the number of enhancers (E1, E2, E3, E4) that 
contain binding-site motifs for TF-A. (B) Regulatory connectivity of enhancer-associated TFs in 
TCR αβ+ and TCR γδ+ IELs purified from the indicated groups of mice. For each IEL population, 
the interactions of all enhancer-associated TFs with a normalized total (IN+OUT) degree >0.75 
are shown. TFs with a normalized total degree of at least 0.75 in either GF or CONV-R cells are 
highlighted in red or blue, respectively. (C) The total IN+OUT degree for all enhancer-associated 
TFs with a normalized total degree >0.75 are hierarchically clustered using a Euclidean distance 
metric allowing categorization of groups of TFs with similar regulatory patterns. TFs are color 
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coded by their degree of connectivity in each colonization group: blue- and red-colored TFs dem-
onstrated a high degree of connectivity in CONV-R and GF IELs, respectively. TFs colored black 
displayed high connectivity in both IEL populations, and those in brown displayed a mixed pattern 
of connectivity.
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List of tables
Dataset S1. Overview of samples and ATAC-seq datasets
A summary of all samples in the study (including read counts), stratified by cell type and coloniza-
tion status.
Dataset S2. Super-enhancers identified in all populations, independent of colonization status, rank 
ordered by signal intensity This dataset encompasses all the super-enhancers presented in Fig. 
S1B. Super-enhancers were identified using the RIESLING pipeline. For each predicted super-
enhancer, chromosome location, predicted boundaries, signal intensity, and most proximal gene 
(independent of orientation) are listed. (A) TCR αβ+ IELs. (B) TCR γδ+ IELs. (C) Both IEL 
populations. (D) CD4+ T cells only. (E) CD8+ T cells only. (F) Both T-cell populations (CD4+ U 
CD8+).
Dataset S3. Pathway analysis within the GeNets-predicted communities from the top IEL super-
enhancers
The GeNets analysis identified eight predicted communities of interconnected super-enhancers 
(applied to the top 250 super-enhancers from the combined population of TCR αβ+ and TCR γδ+ 
IELs independent of host colonization status). Pathway analyses applied to these communities 
identified a number of enriched pathways, described here by community.
Dataset S4. Lineage-specific enhancers independent of colonization status
Differentially accessible enhancers were identified using binomial modeling via DESeq2. Statis-
tical significance, based on a Benjamini–Hochberg-adjusted Wald test, reflects the consistency 
of differences in enhancer accessibility in each cell lineage across all animals regardless of their 
membership in the GF, CONVR, or CONV-D groups (colonization independent). (A) Enhancers 
more accessible in the TCR αβ+ IELs, rank ordered based on the statistical significance. (B) En-
hancers more accessible in the TCR γδ+ IELs. (C) Enhancers more accessible in CD4+ T cells. (D) 
Enhancers more accessible in CD8+ T cells.
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Dataset S5. Pathway analysis of lineage-specific differentially accessible enhancers independent 
of colonization status
Pathway analyses were applied to genes adjacent to enhancers described in Dataset S4. Analyses 
used GO Molecular Function, Biological Process, and Cellular Component and MSigDB Path-
ways. Pathways are rank ordered based on the statistical significance of their enrichment (hyper-
geometric and binomial tests). (A–D) Pathways with increased accessibility in TCR αβ+ IELs (A), 
TCR γδ+ IELs (B), CD4+ T cells (C), or CD8+ T cells (D).
Dataset S6. Pathway analysis of genes near predicted enhancers in IEL populations, independent 
of colonization status
Pathway analyses were performed comparing genes proximal to identified super-enhancers with 
the whole mouse genome as a background and comparing genes proximal to traditional enhanc-
ers with the whole mouse genome. A third comparison, designed to highlight potential functional 
differences between super-enhancers and traditional enhancers, involved a direct comparison of 
genes proximal to super-enhancers with genes proximal to all enhancers [i.e., the set of traditional 
and super-enhancers instead of the mouse genome (mm10)]. Pathways from GO and MSigDB are 
rank ordered based on the statistical significance of their enrichment (hypergeometric and bino-
mial tests). (A) IEL (combined TCR αβ+ and γδ+) super-enhancers vs. mm10. (B) IEL traditional 
enhancers vs. mm10. (C) IEL super-enhancers vs. traditional enhancers. (D) TCR αβ+ super-en-
hancers vs. mm10. (E) TCR γδ+ super-enhancers vs. mm10. (F) TCR αβ+ traditional enhancers vs. 
mm10. (G) TCR γδ+ traditional enhancers vs. mm10. (H) TCR αβ+ super-enhancers vs. traditional 
enhancers. (I) TCR γδ+ super-enhancers vs. traditional enhancers.
Dataset S7. Pathway analysis of genes near predicted enhancers in CD4+ and CD8+ T-cell popula-
tions, independent of colonization status
Pathway analyses were performed as described in Dataset S6. Pathways are rank ordered based 
on the statistical significance of their enrichment (using hypergeometric and binomial tests). (A) 
Peripheral T-cell (combined CD4+ and CD8+) super-enhancers vs. mm10. (B) Peripheral T-cell 
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traditional enhancers vs. mm10. (C) Peripheral T-cell super-enhancers vs. traditional enhancers. 
(D) CD4+ super-enhancers vs. mm10. (E) CD8+ super-enhancers vs. mm10. (F) CD4+ traditional 
enhancers vs. mm10. (G) CD8+ traditional enhancers vs. mm10. (H) CD4+ super-enhancers vs. 
traditional enhancers. (I) CD8+ super-enhancers vs. traditional enhancers.
Dataset S8. Differentially accessible regions of chromatin identified comparing GF to CONV-R 
mice
Included here are statistically significant (P < 0.05, Benjamini–Hochberg-adjusted Wald test) dif-
ferentially accessible enhancers and associated genomic features identified in TCR αβ+ IELs (A), 
TCR γδ+ IELs (B), CD4+ T cells (C), and CD8+ T cells (D). 
Dataset S9. Pathway analysis within the GeNets-predicted communities from the genes adjacent to 
differentially accessible enhancers identified in IELs purified from CONV-R vs. GF mice
Also included are inferred candidate genes (and their pathways) that displayed connectivity and 
known interactions similar to those we observed. (A) Increased accessibility in GF TCR αβ+ IELs. 
(B) Increased accessibility in CONV-R TCR αβ+ IELs. (C) Increased accessibility in GF TCR γδ+ 
IELs. (D) Increased accessibility in CONV-R TCR γδ+ IELs.
Dataset S10. GREAT analysis applied to differentially accessible enhancers and their adjacent 
genes identified in IELs from CONV-R vs. GF mice
Included are statistically significant results (hypergeometric test P < 0.05) from the GO consortium 
and MSigDB. (A–C) Within TCR αβ+ IELs, pathways enriched for genes proximal to enhancers 
demonstrating increased accessibility (A) and decreased accessibility (B), and independent of ac-
cessibility (C). (D–F) Within TCR γδ+ IELs, pathways enriched for genes proximal to enhancers 
with increased accessibility (D), decreased accessibility (E), and independent of accessibility (F).
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Dataset S11. Enhancers classified as microbiota-responsive, based on whether their accessibility 
changes in the GF vs. CONV-D and CONV-R groups
Included are statistically significant (P < 0.05, Benjamini–Hochberg-adjusted Wald test) differen-
tially accessible enhancers and their most adjacent genes, classified as microbiota-responsive in 
TCR αβ+ IELs (A) and in TCR γδ+ IELs (B). Fold-changes and statistics reflect the comparison 
between GF vs. CONV-R groups.
Dataset S12. Analysis of TF circuitry in GF and CONV-R IEL enhancers
TF circuitry based on IN/OUT degree was analyzed using dynamically stitched enhancers. TFs 
shown in boldface have a high degree of connectivity and also are displayed in Fig. 2B. Those 
with an asterisk are also colonization specific. (A) GF TCR αβ+ IELs. (B) GF TCR γδ+ IELs. (C) 
CONV-R TCR αβ+ IELs. (D) CONV-R TCR γδ+ IELs.
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SI Results
We also contrasted the chromatin landscapes of TCR αβ+ vs. TCR γδ+ IELs, independent of colo-
nization status. Our GREAT-based analysis revealed that the most statistically significant enrich-
ment for MSigDB pathways in TCR αβ+ IELs was “Glycosaminoglycan biosynthesis– heparin 
sulfate” (10 genes) (Dataset S5A). Heparan sulfate-binding proteins have been reported to have 
antimicrobial effects in both gut and lung (51). The two most significantly enriched GO Molecu-
lar Functions were “UDP-xylosyltransferase activity” and “Protein xylosyltransferase activity,” 
which were driven by multiple enhancers around three genes (Gxylt2, Xylt1, and Xylt2) and which 
contribute to glycosaminoglycan biosynthesis, including heparan sulfate. T cells with a deficiency 
in heparan sulfate biosynthetic enzymes are hyperresponsive to low-level activation (52).
The most statistically significant MSigDB pathway in TCR γδ+ IELs was N-glycan bio-
synthesis (based on eight distinct genes adjacent to enhancers), including a number of mannosi-
dases (Dataset S5B). N-glycosylation and mannosidase activity are important for T-cell migration 
in an allograft model (53) and serve an important inhibitory role in preventing T-cell activation 
(54). The most statistically significant GO Molecular Function was “Receptor signaling protein 
tyrosine kinase activity,” driven by multiple enhancers around three genes, Erbb4, Kit, and Syk; the 
latter two genes have been identified as factors affecting TCR γδ+ survival in the intestine (55, 56).
The rank order of pathway enrichment in these two IEL lineages differs from that observed 
in CD4+ and CD8+ T cells (compare Dataset S5 C and D with Dataset S5 A and B). For parallel 
GREAT analyses comparing enhancers with the whole mouse genome (mm10), see Datasets S6 
(IELs) and S7 (peripheral T cells).
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SI Materials and methods
Animals. Adult (8- to-10-wk-old) GF male C57BL/6J mice were maintained either in flexible gno-
tobiotic isolators (for the GF and CONV-D groups; Class Biologically Clean Ltd.) or in a specific 
pathogen-free barrier facility (CONV-R group), under a strict 12-h light cycle (light on at 0600, off 
at 1800). Pups were weaned onto a sterilized low-fat, plant polysaccharide-rich chow (B&K Uni-
versal; Product 7378000) that was provided ad libitum. All mice were housed in cages containing 
indigestible cellulosic bedding (Aspen wood shavings; NEPCO). CONV-D mice were colonized at 
3 wks of age by gavage of cecal contents harvested from an adult male CONV-R C57BL/6J donor. 
Gavage was performed using 200 μL of a slurry of cecal contents homogenized in 5 mL sterile 
PBS, with the remaining mixture spread on fur.
All mice were killed in the morning, and all four immune cell populations were isolated in 
parallel from up to four mice simultaneously. Where possible, subsets of mice from different treat-
ment groups (e.g., two GF mice and two CONV-R mice) were killed at the same time to reduce 
technical and day-to-day biases associated with the purification of cell populations and preparation 
of nuclear DNA for ATAC-seq. 
Bacterial 16S rRNA Analysis.
16S rRNA PCR was performed on fecal samples collected from CONV-R, CONV-D, and (as a 
quality control) GF mice. Fecal samples were collected at the time mice were killed, frozen imme-
diately in liquid nitrogen, and stored at −80 °C until analysis. DNA was isolated from samples by 
bead beating and subsequent extraction in 210 μL of 20% SDS, 500 μL buffer A (200 mM NaCl, 
200 mM Trizma base, 20 mM EDTA), and 500 μL phenol:chloroform:isoamyl alcohol (at a ratio of 
25:24:1). Isolated DNA was purified using QIAquick columns (Qiagen) followed by elution in 70 
μL Tris-EDTA. Purified DNA was quantified using the Quant-iT dsDNA assay (broad range; Invi-
trogen) and was normalized to 1 ng/mL. PCR was performed using phased, barcoded primers, and 
amplicons were generated from variable region 4 (V4) of bacterial 16S rRNA genes. Fecal samples 
from the GF mice failed to produce detectable levels of amplicons. Amplicons were subsequently 
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sequenced from CONV-D and CONV-R mice using an Illumina MiSeq (paired-end 250-nt reads). 
Reads were de-multiplexed and clustered based on 97% sequence identity to the Greengenes da-
tabase for operational taxonomic units (OTUs) (57). Novel OTUs from the remaining sequences 
were grouped using the UCLUST method [using QIIME version 1.9 (58)], and taxonomy was as-
signed using RDP 2.11 trained on a custom database aggregating the Greengenes “Isolated named 
strains 16s collection” and the National Center for Biotechnology Information (NCBI) taxonomy 
database.
A phylogenetic tree of the OTUs’ representative V4-16S rRNA sequences was constructed 
and used to calculate Faith’s phylogenetic diversity as well as weighted and unweighted UniFrac 
distances. The number of observed OTUs was also calculated for each sample (rarefied to 5,000 
reads), and binary Jaccard dissimilarities were calculated for each pair of samples. ANOVAs were 
used to test for differences in the means of alpha-diversity metrics (phylogenetic diversity, Shan-
non’s diversity index, observed OTUs) between CONV-D and CONV-R mice, and permutational 
multivariate analyses of variance (PERMANOVA) were used to test for differences in community 
structure (unweighted UniFrac distances, weighted UniFrac distances, and binary Jaccard dissimi-
larities). Indicator species analysis was used to identify specific OTUs that were more strongly 
associated with CONV-D or CONV-R mice. Before this analysis, OTUs that were not detected 
in at least three CONV-D or three CONV-R mice or that had mean relative abundances less than 
0.1% in both groups were removed from the dataset. Significance was assessed by permutation 
tests using 10,000 randomizations, and P values were corrected for false discovery using the Ben-
jamini–Hochberg method.
Isolation of cell populations.
Small intestinal IELs. When mice were killed, the small intestines were excised, placed in HBSS 
lacking calcium and magnesium at 4 °C, rinsed gently with ice-cold HBSS to remove luminal 
contents, dissected along their cephalocaudal axis, and minced into 3- to 5-mm fragments. These 
fragments were agitated gently for 15 min (37 °C) in 15 mL of HBSS containing EDTA (5 mM), 
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and the suspension was passed through a sterile 100-μm mesh nylon filter (Falcon/Corning; no. 
352360). This step was repeated, and the filtrates were combined and centrifuged for 5 min at 500 
× g. Supernatants were discarded, and cell pellets were resuspended in 10 mL of 40% Percoll/
RPMI (RPMI Medium 1640, Gibco; Percoll no.17-0891-01, GE Life Sciences). The suspension 
was subsequently layered over 5 mL of 80% Percoll/RPMI, and the material was centrifuged for 
20 min at 650 × g (18 °C) with the brake off. Cells at the resulting 40%/80% Percoll interface were 
collected, washed once with 50 mL of RPMI, and isolated again by centrifugation (5 min at 500 × 
g). The resulting supernatant was discarded, and cell pellets were transferred to a round-bottomed 
96-well plate for Fc receptor blocking and antibody staining as described below.
Circulating CD4/CD8+ T cells. CD4+ and CD8+ T cells were isolated by collecting ∼500 
μL of whole blood at the time mice were killed in EDTA-containing tubes (BD Microtainer; no. 
365973). Each sample was gently mixed with ∼3 mL of cold HBSS and layered on top of Ficoll 
1.084 (GE Life Sciences; no. 17-5446- 02). Samples were spun at 400 × g for 30 min at 18 °C with 
no brake. After centrifugation, the upper plasma layer was removed, and the entire mononuclear 
layer was transferred to a 50-mL conical tube (Falcon; no. 352098) wetted with a minimal volume 
of cold HBSS. Additional cold HBSS was added to the maximum volume of the tube. Tubes then 
were spun at 500 × g for 10 min (4 °C), and the supernatants were discarded. The pelleted periph-
eral blood mononuclear cells (PBMCs) were resuspended in 50 μL of HBSS and were transferred 
to a round-bottomed 96- well plate for blocking and staining, as described below.
Both cell preparations (IELs, and PBMCs) were incubated on ice for 20 min with anti-
CD16/CD32 (clone 2.4G2; BD) to prevent nonspecific staining during subsequent steps. Cells 
were washed with 200 μL of ice-cold PBS-BSA, centrifuged at 500 × g for 5 min (4 °C), and the 
supernatant was discarded. Cell pellets were resuspended in the appropriate antibody staining 
mix. For IELs, this mix included anti-TCR γδ phycoerythrin (clone eBioGL3; eBioscience), anti-
CD45.2 allophycocyanin (APC)-eFluor780 (clone 104; BD), anti-TCR β V450 (clone H57-597; 
BD), and antiB220 V500 (clone RA3-6B2; BD). For PBMCs, this mix was composed of anti-
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CD8a FITC (clone 53-6.7; BD), anti-CD4 APC (clone RM4-5; eBioscience), anti-TCR β V450 
(clone H57-597; BD), and anti-B220 V500 (clone RA3-6B2; BD).
Live cells were identified by exclusion of the DNA-binding dye 7-aminoactinomycin D 
(7-AAD) (Life Technologies) added to the staining mix at a dilution of 1:1,000. After incubation 
with these reagents in the dark for 20 min on ice, cells were washed with 150 μL of PBS-BSA, 
centrifuged at 500 × g for 5 min (4 °C), and the supernatant was discarded. Cells were kept in the 
dark, on ice, until flow cytometry and cell sorting.
Flow cytometry and cell sorting were performed with a FACSAria III instrument (BD 
Biosciences) in a laminar flow biocontainment hood (BioProtect IV Safety Cabinet; Baker Co.), 
using the manufacturer’s protocol for aseptic sorting. Sheath fluid consisted of autoclaved PBS and 
was prepared no more than 1 day before sorting. Cells were sorted into sterile 1.5-mL tubes in a 
water-cooled jacket maintained at 4 °C. After sorting, cell purity was validated in a post sort; i.e., 
for every sorted population, 10% of the sorted volume was transferred to a new sterile tube and 
analyzed by flow cytometry (see Fig. S1A for the gating strategies).
ATAC-seq.
Transposition and sequencing. Purified, sorted cells (≤50,000 cells per cell type) were prepared 
for ATAC-seq transposition following the original published protocol (5), incorporating modifica-
tions and optimizations (59). Purified cells from FACS were first centrifuged at 500 × g for 10 min 
(4 °C), and the supernatants were discarded. Cell pellets were rinsed with 150 μL icecold PBS and 
centrifuged at 500 × g for 10 min (4 °C). The supernatants were discarded, and cell pellets were 
resuspended in 25 μL of ice-cold lysis buffer [10 mM Tris·HCl (pH 7.4), 10 mM NaCl, 3 mM 
MgCl2, 0.1% (vol/vol) IGEPAL CA-630 (Sigma no. I8896)], followed by centrifugation at 500 
× g for 15 min (4 °C). Supernatants were discarded, and the pellets were kept on ice while being 
gently resuspended in 25 μL of ATAC-seq transposase reaction mixture [12.5 μL 2× Illumina Tag-
ment DNA (TD) buffer; 10.5 μL nuclease-free water; 2.0 μL Tn5 transposase (Illumina/Nextera 
no. FC-121-1030)]. Samples were incubated at 37 °C for 1 h and then were placed immediately on 
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ice, and transposed DNA was isolated using a standard PCR purification kit (QIAGEN MinElute 
no. 28004).
Isolated DNA samples were transferred to a 96-well PCR plate and amplified for nine 
cycles using unique 8-bp indexes per sample (Dataset S1). Cycling conditions were as described in 
the original ATAC-seq protocol (5). Following this first amplification, samples were enriched for 
smaller fragments using solid-phase reversible immobilization (SPRI) beads. Briefly, after PCR 
amplification, samples were mixed with SPRI beads (Beckman Coulter/Agencourt AMPure XP; 
no. A63881) at an SPRI to DNA ratio of 0.5 (25 μL SPRI beads). After a 5-min incubation, the 
PCR plate was transferred to a magnet stand for separation, and the supernatant was transferred 
to a new 96-well plate. Additional SPRI beads were added to an SPRI to DNA ratio of 1.2 (65 μL 
of SPRI beads). Samples were mixed at room temperature for an additional 5 min and then were 
transferred to a magnet stand for bead separation. The resulting supernatant was discarded, and the 
magnet-immobilized beads were rinsed twice with 80% ethanol. The ethanol-washed beads were 
airdried following the manufacturer’s instructions. DNA was subsequently eluted in 20 μL of 10 
mM Tris·HCl, pH 8.0 (Integrated DNA Technologies; no.11-05-01-13). The size-selected DNA 
was subsequently amplified via a second nine-cycle PCR using the same unique 8-bp indexes per 
sample and the cycling conditions described in the original ATAC-seq protocol (5). Amplicons 
were purified using a standard kit (QIAGEN MinElute no. 28004).
The amplified, uniquely indexed samples were combined and normalized before pooling 
and then were sequenced to a target of 25 million reads per sample. Pools were run on an Illumina 
NextSeq 75-cycle high-output flow cell (paired-end, 2 × 40+8 bp index) and HiSeq high-output 
flowcell (paired-end, 2 × 50+8 bp index). To minimize group effects, samples were chosen so that 
each sequencing pool included mice from different experimental groups. Samples that were under-
sequenced were repooled for subsequent runs.
Computational pipeline. The RIESLING pipeline was developed to process and analyze 
ATAC-seq data. RIESLING is a Pythonbased, open-source (license: MIT) pipeline, available at 
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https:// github.com/GordonLab/riesling-pipeline. The pipeline was designed for de novo predic-
tion of putative enhancer and superenhancer regions from either single or multiple samples, with 
the option of including background or control samples (if available) for comparison. The full 
pipeline, detailed in Fig. S2, consists of mapping paired-end sequence data to host genomes (using 
Bowtie 2), mitochondrial read filtering (a nuisance in ATACseq, given the open nature of mito-
chondrial DNA), removal of identical PCR duplicate reads, quality filtering (using adjustable pa-
rameters, with a default mapping quality ≥10), and hotspot/ blacklist masking (from the ENCODE 
and modENCODE consortia, with varying availability depending on the host organism, or from 
internally generated experimental hotspots).
Filtered data were used to perform multistage enhancer prediction, beginning with peak 
calling, in which regions with signal higher than background (peaks) were identified using a stan-
dard Poisson modeling technique from ChIP-seq [user adjustable, with a default Model-based 
Analysis of ChIP-Seq (MACS) (60) and a significance cutoff of P < 1 × 10−9 ]. A window around 
known transcription start sites was subsequently masked because of their generally low signal-to-
noise ratio in ATAC-seq data (user adjustable, with a default masking of ±2.5 kb), and the raw, 
sequenced read depth underlying the identified peaks was computed and summarized using bam-
liquidator (https://github.com/bradnerlab/ pipeline). Peaks were additionally grouped using one of 
three strategies to merge adjacent peaks: (i) unstitched (only the raw peaks without merging); (ii) 
fixed stitching, in which peaks within a user-definable window (generally 12.5 kb) are merged to 
represent one potential large super-enhancer; or (iii) dynamic stitching, in which the rate of change 
of peaks is computed within a window, and the window size is slowly increased to determine an 
inflection point. Using these three different approaches to aggregating peaks, predicted enhancers 
were graphed using the aggregate signal underlying each enhancer region. Super-enhancers can be 
stratified from traditional enhancers by drawing a tangent line to this graph and placing the cutoff 
where the slope of this line equals one (this distinction is somewhat arbitrary; see refs. 10 and 11).
Differential accessibility analysis. Differentially accessible regions of chromatin were 
identified and classified by applying a negative-binomial model (DESeq2) (61) to counts data out-
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put from the RIESLING pipeline. The RIESLING pipeline was used to preprocess (filter, blacklist, 
de-replicate reads, call peaks, and so forth) data from each sample, compute the raw read depth, 
and then generate a count matrix (read depth per locus in each sample) for input to DESeq2. (Users 
also can input these data to alternative analytical packages, including edgeR and baySeq.) Peaks 
were selected for inclusion in the counts matrix if they were identified as statistically significant 
(based on the MACS Poisson model described above) in any input sample; any overlapping peaks 
were merged. Because adjacent peaks are likely to represent the same enhancer regions, RIES-
LING automatically expands peaks to include nearby peaks within 50-bp, 500-bp, and 1,000-bp 
windows (in addition to the unmerged raw data). DESeq2 is then invoked with the default param-
eters and run at both the genome position level (mm10) and at gene level for comparison (binning 
peaks and their associated read depth by proximal gene). For classifying microbiota-responsive 
enhancers, we considered groups to be significantly different with P < 0.05.
Normalization. Numerous normalization approaches were compared to determine the 
most appropriate choice. For enhancer and super-enhancer characterizations (nondifferential anal-
yses), we used bamliquidator to produce normalized scores of the ATAC-seq signal. This approach 
takes each called peak, combined with the underling raw sequencing data, and computes the raw 
read counts under each peak, divided by the total sequencing depth and the peak width.
For differential accessibility analyses, we compared results obtained from DESeq2 when 
using raw counts data, counts data aggregated by nearby peaks, or counts data following bamliq-
uidator normalization to sequencing parameters (which may violate assumptions of DESeq2’s me-
dian normalization model). Comparing these three options revealed that providing raw counts data 
to DESeq2 generated the most conservative estimates of differential accessibility (i.e., the fewest 
number of differentially accessible regions); therefore we selected that method for our analyses.
DESeq2’s standard normalization approach uses counts data from all peaks and applies a 
median-of-ratios method described in ref. 61 to predict unchanging (pseudoreference) regions. We 
also considered guiding this median normalization by providing predictions of unchanged (consti-
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tutively accessible or condensed) chromatin regions, i.e., de novo regions chosen from overlapping 
peaks from our input data and available peaks from public ENCODE datasets. Our de novo peaks 
were derived from those shared across groups (GF ∩ CONV-R ∩ CONV-D) and in intersections of 
cell types (CD4+ ∩ CD8+, TCR αβ+ ∩ TCR γδ+ IELs ∩ PBMC) and at varying overlap percent-
ages (10, 50, or 90% bp overlap). In these permutations, DESeq2 performed either comparably to 
or worse than (i.e., less conservatively, calling more regions as differentially accessible) simply 
applying the standard median-of-ratios method to all the input counts data. Using the available 
mouse ENCODE data (62) resulted in normalization effects similar to those seen using all raw 
counts data, perhaps because the original mouse ENCODE data (i) were generated from heteroge-
neous tissues not directly comparable to our datasets and (ii) used ChIP-seq. In light of these alter-
natives, the data in our study reflect the standard DESeq2 median-of-ratios method applied to the 
raw input counts data. Pathway analyses. GeNets (https://apps.broadinstitute.org/genets) was used 
to identify clusters of functionally associated genes and to group genes by community. The GeNets 
random forest classifier was based on the GeNets Metanetwork 1.0 training database, which en-
compasses InWeb3, ConsensusPathDB, and known drug–target interactions. If multiple enhancers 
mapped to a single gene, they were coalesced into one gene for GeNets analysis. Analyses and 
community predictions were restricted to the top 250 enhancer-associated genes ranked by ATAC-
seq signal (for super-enhancers) or by P value (when comparing two different colonization states). 
GeNets community enrichment significance is based on a Bonferroni-adjusted hypergeometric 
test. The GeNets empirical P values for network connectivity are based on gene network density. 
The number of edges (interactions between genes) out of the total number of possible edges (the 
density) is computed for a given input network as well as for randomly sampled sets of genes; the 
density is considered significant if it is greater than that of 95% of the randomly sampled gene sets.
Gene overrepresentation analyses were performed GREAT (18). GREAT 3.0 was run on 
predicted enhancer locations (provided from RIESLING) and using the mm10 mouse genome an-
notation. For identifying proximal genes, the configured parameters of “basal plus extension” were 
used (with parameters left at their default values for gene regulatory domain definitions). Back-
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ground regions were provided where applicable (to remove potential biases from over- or under-
represented regions from our original peak calling), or the whole mm10 genome was used where 
appropriate. DESeq2 differential accessibility data were filtered at P < 0.05 for use by GREAT. 
Additional pathway and overrepresentation analyses were performed using IPA (QIAGEN). IPA 
was provided log ratios, P values, and the NCBI ID of the nearest gene for each predicted enhancer. 
Analyses were run using only the IPA data from “Mouse restricted to Experimentally Observed 
data from Epithelial Cells and Immune Cells.”
Analysis of TF Regulatory Circuitry. Network analysis was performed using the Col-
tron software package (34) available at https://pypi. python.org/pypi/coltron. In each IEL sample, 
we identified all dynamically stitched super-enhancer regions associated with TFs. These super-
enhancer–associated TFs became the cohort of nodes for the network analysis. Edges were defined 
as predicted TF-binding sites within ATAC-accessible regions found inside super-enhancers. Thus, 
for any given TFi, connectivity could be described as how it is regulated itself (IN degree) and how 
it regulates the super-enhancers of other TF nodes in the network. IN degree and OUT degree are 
normalized from 0 to 1 where 0 indicates that no TF-binding sites are predicted, and 1 indicates 
that all TFs have a predicted binding site. Multiple TFbinding sites in a super-enhancer from the 
same factor are considered a single edge in the degree calculations. Enriched TF-binding sites 
were predicted using the FIMO algorithm (63) trained on TF position weight matrices defined in 
the TRANSFAC database (64). A false-discovery rate cutoff of 0.01 was used to identify enriched 
TF-binding sites.
54
Supplemental figure legends
Fig. S1.
FACS sorting strategies and reproducibility of ATAC-seq datasets. (A) Gating strategies for both 
IEL populations. Live TCR αβ+ and TCR γδ+ IELs from the small intestine were sorted simulta-
neously. (B) Venn diagrams showing the total number of putative enhancers within and between 
the four cell types studied. (C) ATAC-seq read counts per predicted enhancers identified from each 
cell preparation were normalized using a negative binomial model (via DESeq2). Pairwise com-
parisons were then performed within a given treatment group. Pearson correlation values (mean ± 
SEM) are plotted for each group.
Fig. S2.
Overview of the RIESLING pipeline. The RIESLING pipeline was developed to characterize en-
hancer regions in ATAC-seq data rapidly and to generate output for processing with additional 
tools (e.g., DESeq2, edgeR, baySeq, and others) to identify differentially accessible regions of 
chromatin. (A) Input to this pipeline is de-multiplexed paired-end sequencing reads. (B–D) Reads 
are mapped to a host genome (via bowtie2) (B) and then are filtered for mitochondrial reads and 
ENCODE blacklists (65) (C) and de-duplicated (D). (E) Peaks are called using a user-selectable 
peak caller (60). (F) The preprocessed data undergo signal aggregation using bamliquidator. (G 
and H) RIESLING internally filters transcriptional start sites (TSS) and promoters (G) and then 
predicts enhancer regions using one of three peak stitching approaches: unstitched (raw peaks); 
dynamic stitching, based on the rate of change of enhancer prediction vs. a growing window; or 
fixed stitching in which peaks within a user-selectable parameter (generally 12.5 kb) are merged 
(H). (I) These regions are then ranked by signal (normalized read depth), and super-enhancer (SE) 
regions are separated from traditional enhancers. (J and K) RIESLING calls enhancer-proximal 
genes based on user-specified parameters (J) and prepares a counts matrix for differential acces-
sibility analysis (K). (L–N) For differential accessibility analysis, the output of RIESLING is used 
as input to DESeq2 to generate quality control graphs (L) and differential accessibility analyses 
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(M), including optional pathway and overrepresentation analyses (N). For additional details of the 
pipeline and source code availability, see SI Materials and Methods, Computational pipeline.
Fig. S3.
The enhancer landscape of TCR αβ+ and TCR γδ+ IELs and peripheral CD4+ and CD8+ T cells, 
independent of colonization status. (A) Hierarchical clustering of enhancers identified in ATAC-
seq datasets shows clear separation of IEL populations from circulating T cells. Clustering was 
performed on Jaccard distance metric scores between peaks from a given cell type (shown in blue 
shading where a value of 1.0 reflects complete overlap). (Left) All enhancers. (Right) Super-en-
hancers. (B) Distribution of enhancer signals in TCR αβ+ IELs and TCR γδ+ IELs, demonstrating 
a hockeystick asymmetric distribution. Super-enhancers were stratified from traditional enhanc-
ers by the point on the exponential curve where the slope approaches 1. The vertical dashed line 
represents the cutoff between traditional and super-enhancers. A subset of super-enhancers and 
their adjacent genes is highlighted. (C) Distribution of enhancer signals in CD4+ and CD8+ T 
cells. Super-enhancers with the top-ranked signal intensity are annotated with their most proximal 
gene. (D) The Bach2 super-enhancer overlaid on normalized sequencing data (reads per kilobase 
per million reads, within a 50-bp bin) from the TCR αβ+ and TCR γδ+ IEL populations. Genomic 
information for Bach2 and its neighbors are from mm10 RefSeq.
Fig. S4.
Predicted GeNets communities from both IEL lineages. (A) A network and community clustering 
analysis performed using GeNets, applied to the top 250 super-enhancer–associated genes shared 
by TCR αβ+ and TCR γδ+ IELs, independent of colonization status. Nodes represent genes, and 
edges (lines) represent gene–gene interactions. Note that there is significant connectivity between 
networks (P < 0.005; permutation test of nodes). See Datasets S6 and S7 for an alternative GREAT-
based analysis of pathways enriched in the various purified cell populations independent of colo-
nization status. (B) Each individual community is expanded here for both TCR αβ+ and TCR γδ+ 
IELs, with each node representing a super-enhancer–associated gene and each edge representing a 
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gene–gene interaction (based on a network including ConsensusPathDB and InWeb3; see SI Mate-
rials and Methods, Pathway analyses). A description of each gene and analyses of overrepresented 
pathways in each community are available in Dataset S3.
Fig. S5.
Enhancer populations distinguish IEL lineages. (A) The dynamic stitching model from RIESLING 
applied to the IEL population (independent of colonization status), demonstrating a window of 
2.5 kb for grouping together nearby predicted enhancers. (B) Enhancers distinguishing lineages 
independent of host colonization status. (C) Enhancers distinguishing TCR αβ+ IELs as a function 
of colonization status. (D) Enhancers distinguishing TCR γδ+ IELs as a function of colonization 
status. (E) Histograms representing the distribution of fold change (log2) in dynamically stitched 
enhancers identified as statistically significant to our stringent threshold (P < 5 × 10−5) in GF vs. 
CONV-R TCR αβ+ and TCR γδ+ IELs. (F) A histogram of fold change (log2) of dynamically 
stitched enhancers identified as statistically significant (P < 5 × 10−5) in CD4+ vs. CD8+ T cells.
Fig. S6.
Comparison of gut microbial community structure in CONV-R and CONV-D mice. Bacterial 16S 
rRNA analysis was performed on fecal samples obtained when 8-wk-old mice were killed. CONV-
D animals were colonized at 3 wks of age. The fecal microbiota of CONV-D and CONV-R animals 
had similar alpha-diversity with no significant differences detected in Faith’s phylogenetic diver-
sity (P = 0.395, ANOVA), Shannon’s diversity (P = 0.301, ANOVA), or the number of observed 
97% ID OTUs that survived our initial filtering and rarefaction (P = 0.646, ANOVA). (A) Heatmap 
of the relative abundances of the most strongly associated OTUs for the CONV-D and the CONV-
R groups of mice, as judged by the differences in their indicator values. Relative abundance is 
calculated as the base 10 log of the number of reads (plus one) per 5,000 reads. (B) Phylogenetic 
tree showing evolutionary relationships between the V4-16S rRNA sequences of the significant 
indicator OTUs. OTUs in red were positively associated with CONV-R mice, and OTUs in blue 
were positively associated with CONV-D mice. An approximately-maximum-likelihood phyloge-
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netic tree was constructed using the FastTree method implemented in QIIME. PERMANOVA re-
vealed significant differences in the phylogenetic composition and structure of the fecal microbiota 
of CONV-D compared with CONV-R mice based on a number of metrics [unweighted UniFrac 
distances (P = 0.001, R2 = 0.422); weighted UniFrac distances (P = 0.001, R2 = 0.571); and binary 
Jaccard dissimilarities (P = 0.001, R2 = 0.298)].
Fig. S7.
Track graphs comparing normalized median ATAC-seq signals obtained from analysis of TCR αβ+ 
IELs purified from CONV-R and GF mice. Tracks represent the normalized signal at enhancers 
near Stat1 and Stat3 and demonstrate the increased signal at Stat3 in GF TCR αβ+ IELs compared 
with CONV-R TCR αβ+ IELs (P < 0.05, Benjamini–Hochberg-adjusted Wald test). Binding motifs 
for a subset of TFs implicated in the IEL TF regulatory circuitry are annotated; outlined in red are 
the JUN/FOS and MAFK bZIP TFs that have binding sites in Stat3 but not in Stat1. Both TCR αβ+ 
and TCR γδ+ IELs show enrichment in GF mice compared with CONV-R mice at a second (in-
tronic) enhancer (P < 0.05, Benjamini–Hochberg-adjusted Wald test). No statistically significant 
differences were noted between ATAC-seq signals from enhancers in Stat1 when comparing the 
IEL populations from GF and CONV-R animals. For a more global view of differential accessibil-
ity, see Fig. S5.
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Supplemental figures
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Future Directions
This thesis was enabled by the bleeding edge of technology. At the start of these experiments, and 
during an unpublished proof-of-concept experiment, ATAC-seq was nascent. It was unclear if the 
technology could be adapted from its original paper (which looked primarily at human CD4+ T 
cells) to subpopulations of mouse immune cells, and used to call putative enhancer loci. My stud-
ies suggest one potential mechanism by which the microbiota induces durable effects in its host. 
Several follow-up studies are warranted. 
First, although ATAC-seq is in part empowered by its histone-agnostic approach to chro-
matin characterization, detailed data on individual histone modifications would be very valuable 
in determining which specific modifications may underlie changes in chromatin accessibility. At 
the start of this project, this wasn’t feasible with such small cell populations, though some recent 
technologies (iChIP (Lara-Astiaso et al. 2014)) may be of value when applied to these and/or other 
populations. iChIP is an index-first modification to ChIP-seq that could potentially assay numer-
ous histone marks in small populations of cells. Unfortunately, in a small collaboration with my 
colleague David Russler-Germain, we were unable to reproduce this technique. Since then, other 
techniques have been published aiming to enable ChIP-seq and related techniques using small 
numbers of cells, including Mint-ChIP (a multiplexed ChIP-seq-based approach employing linear 
amplification (van Galen et al. 2015)), scM&T-seq (parallel, single-cell parallel sequencing of the 
transcriptome and methylome (Angermueller et al. 2016)), and single-cell versions of DNAse-seq 
and ATAC-seq (Jin et al. 2015; Buenrostro et al. 2015; Cusanovich et al. 2015). An alternative ap-
proach would be to look even more globally at chromatin architecture. One novel method (Chro-
mATin, Linhoff et al. 2015) takes this global view, and provides 3D chromatin architecture in large 
and structurally complex tissues. This technique, which uses high-resolution imaging combined 
with fixation and immunostaining, could potentially be applied across the layers of the small in-
testine, where marked differences in chromatin landscape may exist between the same cell type 
localized at the junction between the epithelium and underlying lamina propria, or deeper within 
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the submucosa (e.g., tissue-resident macrophages or neurons traversing the intestinal layers may 
show markedly different chromatin compaction or localization of specific histones).
Secondly, this work would be enhanced by exploring potential pharmacologic or dietary 
components that influence enzymes and pathways responsible for microbiota-mediated host chro-
matin remodeling and histone modification. Recent work has suggested that high dietary fat intake 
can induce significant changes in hepatic chromatin landscape (assayed by FAIRE-seq; a common 
formaldehyde cross-linking technique that is similar to DNase-seq in 4–6 week-old C57BL/6J and 
DBA/2J mice fed a standard 10% fat/kcal vs 30% fat/kcal diet for eight weeks) and related tran-
scriptional pathways (via hepatic RNA-seq) (Leung et al. 2014). 
It would be fascinating to apply this approach to the study of populations suffering from 
malnutrition. The literature on epigenetic impacts of malnutrition is complex, and largely focused 
on either single nutrient deficiencies, or on broad studies of methylation. For example, one recent 
study identified significant perturbations (generally hypomethylation) in the mouse sperm methy-
lome following parental undernutrition (Radford et al. 2014). In one of the few studies of under-
nourished humans, whole peripheral blood showed differential methylation at numerous loci — 
including some linked to the insulin receptor — in individuals with prenatal exposure to the Dutch 
Hunger Winter (at the end of World War II) (Tobi et al. 2014). It could be extremely informative 
to apply the approaches outlined in this thesis to the gnotobiotic mouse model described in the Ap-
pendix, where animals were colonized with culture collections generated from the fecal microbiota 
of Bangladeshi children with severe acute malnutrition or with healthy growth phenotypes, fed a 
diet representative of those consumed by the donors. In these studies, weight loss phenotypes with 
associated alterations host energy metabolism were dependent on the presence of an enterotoxi-
genic strain of Bacteroides fragilis (ETBF). The weight loss phenotype could be prevented by the 
presence of a non-toxigenic strain, was diet-dependent, and could be transmitted across genera-
tions. We used ATAC-seq to characterize the chromatin landscape in splenic CD4+ and CD8+ T 
cells harvested from these mice. Although we noted few statistically significant changes between 
mice harboring the stunted donors ETBF(+),NTBF(-) culture collection versus the healthy donors 
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NTBF(+),ETBF(-) culture collection, our work could be limited by our choice of splenic T cells, 
which was restricted by sample availability. A logical follow-up series of experiments would be 
to generate ATAC-seq profiles from IELs or other cell populations exposed more directly to the 
microbiota and its products (e.g., hepatic Kupffer cells). 
Other intergenerational models of malnutrition are also ripe for investigation, including 
one of a collaborator who has identified that maternal undernutrition in mice can result in meta-
bolic disease and insulin resistance in offspring (reviewed in Patti 2013). It is possible that this 
intergenerational phenotype reflects microbial contributions to the host, either during in utero de-
velopment or from postnatal colonization.
Finally, it will be of value for future researchers to expand the computational platform and 
associated visualization tools developed in this thesis. Since this study began, the broad field of 
epigenetic profiling has expanded to include more expression data, frequently by parallel RNA-
seq of samples. Integration of RNA-seq data into the RIESLING pipeline for enhancer prediction 
could be helpful, however not without potential complications. RNA recovered from cells after 
their purification may not accurately reflect the features of gene expression in vivo. Notably, the 
state of chromatin can be more indicative of cell identity and cell state than gene expression data 
(Stergachis et al. 2013), and chromatin can encode functional capabilities that are not reflected in 
RNA (Samstein et al. 2012; John et al. 2011). Additionally, as the epigenetic field has expanded, 
many studies now focus on even smaller cell populations, including the use of single-cell ATAC-
seq. Expanding this software toolkit to analyze single-cell experiments could be of great value 
to future research, and would help standardize what can be otherwise piecemeal analytical ap-
proaches.
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Effects of a gut pathobiont in a gnotobiotic mouse
model of childhood undernutrition
Vitas E. Wagner,1,2* Neelendu Dey,1,2,3* Janaki Guruge,1,2 Ansel Hsiao,1,2 Philip P. Ahern,1,2
Nicholas P. Semenkovich,1,2 Laura V. Blanton,1,2 Jiye Cheng,1,2 Nicholas Griffin,1,2
Thaddeus S. Stappenbeck,4 Olga Ilkayeva,5 Christopher B. Newgard,5,6,7,8 William Petri,9
Rashidul Haque,10 Tahmeed Ahmed,10 Jeffrey I. Gordon1,2†
To model how interactions among enteropathogens and gut microbial community members contribute to
undernutrition, we colonized gnotobiotic mice fed representative Bangladeshi diets with sequenced bacterial
strains cultured from the fecal microbiota of two 24-month-old Bangladeshi children: one healthy and the other
underweight. The undernourished donor’s bacterial collection contained an enterotoxigenic Bacteroides fragilis
strain (ETBF), whereas the healthy donor’s bacterial collection contained two nontoxigenic strains of B. fragilis
(NTBF). Analyses of mice harboring either the unmanipulated culture collections or systematically manipulated
versions revealed that ETBF was causally related to weight loss in the context of its native community but not
when introduced into the healthy donor’s community. This phenotype was transmissible from the dams to their
offspring and was associated with derangements in host energy metabolism manifested by impaired tri-
carboxylic acid cycle activity and decreased acyl–coenzyme A utilization. NTBF reduced ETBF’s expression of
its enterotoxin and mitigated the effects of ETBF on the transcriptomes of other healthy donor community
members. These results illustrate how intraspecific (ETBF-NTBF) and interspecific interactions influence the
effects of harboring B. fragilis.
INTRODUCTION
Undernutrition is the leading cause of childhood mortality worldwide;
it is not due to food insecurity alone but rather reflects a complex and
incompletely understood set of interactions involving a variety of factors
that operatewithin and across generations (1–4). Among these factors is
the gut microbiota. A recent culture-independent study of fecal micro-
biota samples collected monthly from members of a Bangladeshi birth
cohort with healthy growth phenotypes identified age-associated
changes in the representation of bacterial species during the first 2 years
of postnatal life (5). These age-discriminatory species together define a
developmental program for the microbiota that is shared across bio-
logically unrelated Bangladeshi infants and children (5). Children with
moderate or severe undernutrition exhibit disruptions in this program,
resulting in microbial communities that appear younger than those of
chronologically age-matched healthy individuals (5, 6). Clinical studies
have provided evidence thatmicrobiota immaturity in children with se-
vere acute undernutrition is not repaired when they are fed therapeutic
food supplements (5). Transplantation of fecal microbiota from chil-
dren with healthy growth phenotypes, or immature microbiota from
chronologically age-matched undernourished children, into germfree
mice fed diets similar to those consumed by the human donors has
provided preclinical evidence for a causal role of the gut community
indisease pathogenesis (6–8). Youngmouse recipients of undernourished
donors’ microbiota exhibit growth faltering, manifested in part by a
reduced rate of lean body mass gain compared to recipients of healthy
donors’ microbiota. These differences are not associated with differ-
ences in food consumption (6).Adultmouse recipients of undernourished
donor’s microbiota exhibit a weight loss (wasting) phenotype (7, 8).
A large enteropathogen burden is associated with childhood under-
nutrition (9, 10). However, the effects of microbiota configuration on
enteropathogen invasion and burden, or how community context influ-
ences the expressed properties of organisms classified as enteropatho-
gens in children at risk for or already showing undernutrition, remain
poorly understood. Identifying gut community configurations that are
resistant to invasion or accommodate organisms currently classified as
enteropathogens without supporting their ability to produce deleterious
host effects has potential diagnostic and therapeutic implications.
Bacteroides fragilis provides amodel for examining how community
context, including intraspecific interactions involving different strains
of a given species and interspecific interactions involving different spe-
cies, affects the properties of an enteropathogen and its effects on the
host. Enterotoxigenic B. fragilis (ETBF) strains contain one of three
alleles of B. fragilis toxin (bft-1, bft-2, and bft-3) in their 6-kb pathoge-
nicity island (BfPAI). The bft locus encodes a zinc-dependent metallo-
protease, fragilysin, that perturbs gut barrier function through cleavage
of E-cadherin at epithelial cell adherence junctions (11). ETBF strains
cause diarrhea in children residing in Bangladesh (12, 13). Nontoxigenic
B. fragilis strains (NTBF) lack bft. Thus, B. fragilis can be viewed as a
potentially pathogenic symbiont (pathobiont) on the basis of the pres-
ence or absence of this gene, or more broadly, on the basis of its com-
munity context.
Here, we describe a gnotobiotic mouse model for analyzing how
intraspecific and interspecific interactions determine the effects of
ETBF. We started with fecal samples collected from Bangladeshi
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children who were participants in a previously completed birth cohort
study (14). Using anthropometric scores to define healthy growth ver-
sus stunting and wasting (15), and a polymerase chain reaction
(PCR)–based assay that targeted bft, we selected two chronologically
age-matched individuals: one markedly stunted, underweight, and
ETBF-positive, and the other with a healthy growth phenotype who
was ETBF-negative but NTBF-positive. We transplanted intact un-
cultured fecal microbiota samples, collected from these two children
at 24 months of age, into adult germfree mice. These gnotobiotic mice
were fed cooked diets containing ingredients embodying those con-
sumed by the population from which the microbiota donors were
selected. Finding that the severely stunted and underweight but not
the healthy donor’s microbiota transmitted a weight loss phenotype
to recipient animals and subsequently to their offspring, we performed
follow-up transplant studies using clonally arrayed collections of se-
quenced anaerobic bacterial strains cultured from the donors’ fecal
samples. These culture collections allowed us to dissect microbe-
microbe and host-microbe interactions by testing the effects of sev-
eral types of manipulations: (i) removing the ETBF strain from the
stunted donor’s cultured community, (ii) introducing the ETBF strain
into the healthy donor’s culture collection together with or in lieu of
its own NTBF strains, and (iii) introducing the NTBF strain into the
stunted donor’s culture collection together with or in lieu of its own
ETBF strain. Microbiota community structure and gene expression,
microbial and host metabolism, and host weight and immune pheno-
types were characterized as a function of these alterations.
RESULTS
Uncultured fecal gut microbiota from an underweight donor
confers weight loss on gnotobiotic mice
Weused anthropometric data collected frommembers of a birth cohort
study (14) of 100 children living inMirpur thana inDhaka, Bangladesh,
to define whether they were healthy or undernourished (table S1).
Those with height-for-age z scores (HAZ) greater than or equal to −2
were classified as “healthy,”whereas those with scores less than or equal
to −3 were deemed severely stunted. At 18 months, 30 and 25 children
satisfied these criteria for healthy and severely stunted, respectively,
whereas at 24 months, 27 and 20 children received these designations;
the remaining children were classified as moderately stunted (HAZ be-
tween −2 and −3). A PCR-based screen for ETBF targeting all three
fragilysin gene subtypes (14) was performed using DNA isolated from
fecal samples that had been collected from these children at 18 and
24 months of age. The results revealed that ETBF was variably present
between individuals andwithin a given individual over time, with a total
of 25% of 18-month-old and 14% of 24-month-old children having a
positive test (table S1). In this small cohort, ETBF carriage was not sig-
nificantly correlated with indices of linear or ponderal growth [HAZ,
weight-for-age z score (WAZ), and weight-for-height z score (WHZ)
measured at 12 and 24 months of age (P = 0.8 and P = 0.4, P = 0.7
and P = 0.2, and P = 0.5 and P = 0.2, respectively; two-tailed Student’s
t test)]. We combined anthropometric and PCR data to select fecal
samples collected at 24months from two children: (i) a healthy individ-
ual (child ID 7114 in table S1) with a HAZ score of −0.71, aWAZ score
of −1.49, and aWHZ score of −1.62 who was ETBF-negative at the two
time points tested, and (ii) a severely stunted and moderately
underweight individual (child ID 7004) with a HAZ score of −3.02, a
WAZ score of−2.51, and aWHZ score of−1.34whowas ETBF-positive
at both time points. Of the 35 individuals with a positive ETBF test at
either time point, only this stunted/underweight child was positive at
both 18 and 24 months of age. Fecal samples obtained from members
of this singleton birth cohort were screened for parasites using micro-
scopic methods (5); neither of the two donors tested positive (see
Materials and Methods for details).
To define the effects of diet and these two childrens’ gutmicrobiota on
host biology, we generated three representative versions (embodiments)
of the diets consumedby thepopulation represented by thedonors. Todo
so, we determined the relative daily caloric contributions of various
selected ingredient types, based on a study by Arsenault and coworkers
(16). Selection of specific food items as representative of each ingredient
type was based on consumption incidence surveys tabulated by Islam
et al. (17), and the results were incorporated into a database consisting
of 54 food ingredients. We filtered this database to remove items con-
sumed by <20% of households and categorized each of the remaining
39 items (see Materials and Methods for additional details). From the
resulting diet ingredientmatrix, we randomly sampled (without repla-
cement) one item each from cereals, pulse vegetables, roots/tubers,
leafy vegetables, fruits, and fish, plus three nonleafy vegetables, to pop-
ulate three separate diet lists. Using the U.S. Department of Agricul-
ture National Nutrient Database for Standard References (18), we
determined the caloric information for each ingredient and subse-
quently calculated proportions required to match the predetermined
contributions of each ingredient type. Food items were cooked in a
manner intended to simulate Bangladeshi practices, and the resulting
three embodiments of a Bangladeshi diet were sterilized by irradiation.
This approach allowed us to generate several representative Bangladeshi
diets that were not dominated by the idiosyncrasies of a single individ-
ual’s diet or by our own biases. The composition and results of
nutritional analysis of the three diet embodiments are described in
table S2 (A and B). The nutritional requirements of mice and children
are compared in table S2C.
The results of a 12-year survey of demographic variations in the
nutritional status of 16,278 Bangladeshi children found no signifi-
cant sex differences in WHZ, WAZ, or HAZ (19). Therefore, in these
and subsequent experiments, we eliminated gender as an experimental
variable and only studied male mice. We gavaged separate groups of
8- to 9-week-old germfree C57BL/6 mice with the intact uncultured
fecal microbiota samples obtained from the healthy or stunted/
underweight Bangladeshi donors (two independent experiments; n =
4 singly caged mice per donor microbiota per experiment; see fig.
S1A for study design). Fecalmicrobiota transplantation occurred 2 days
aftermice had been switched from an irradiated, nutritionally complete,
low-fat/high-plant polysaccharide (LF/HPP)mouse chow that they had
received since weaning to the first of the three embodiments of the
Bangladeshi diet. Animals were subsequently fed, ad libitum, embodi-
ment 1 for 1 week, followed by embodiment 2 for 1 week, and finally
embodiment 3 for 1 week, with frequent sampling of their fecal micro-
biota during the course of each diet. Sequencing PCR amplicons gener-
ated from variable region 4 (V4) of bacterial 16S ribosomal RNA
(rRNA) genes present in the donor’s fecal sample and in fecal samples
collected over time from recipient gnotobiotic mice (table S3) provided
an in vivo assay of colonization efficiency for each human donor sam-
ple. 16S rRNA sequencing reads were grouped into operational taxo-
nomic units (OTUs) on the basis of a threshold of ≥97% nucleotide
sequence identity (97% ID). The results revealed that at the conclusion
of the experiment, 65.8 ± 2.5% (mean ± SEM) of OTUs in the stunted/
underweight donor’s fecal microbiota sample and 68.4 ± 8.8% (mean ±
SEM) of the OTUs in the healthy donor’s microbiota were detectable in
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recipient mice (that is, each OTU had a relative abundance of≥0.1% in
≥1% of fecal samples obtained from the animals).
Although gnotobiotic animals colonized with the healthy donor’s
intact uncultured fecal microbiota maintained weight, recipients of
the severely stunted/underweight donor’s intact uncultured fecalmicro-
biota exhibited progressive and significant weight loss (P < 0.005, paired
two-tailed Student’s t test, comparison of final versus initial weights
between the two treatment groups; Fig. 1A). In contrast to mice colo-
nized with the healthy donor’s microbiota, those that received the
stunted donor’s microbiota exhibited statistically significant weight
loss at 10 days postgavage (dpg), during consumption of diet embod-
iment 2. Weight loss in this group worsened progressively, reaching
31 ± 6% (mean ± SEM) of original starting weight by 21 dpg (P <
0.001, two-tailed Student’s t test, comparison of final weights; Fig.
1A); in a linear mixed-effects model, both dpg and the interaction
between microbiota and dpg were significant factors affecting weight
throughout the experiment (P < 1 × 10−7 for each). Food consump-
tion was not different between the two treatment groups as their
weight phenotypes diverged. The relative abundance of B. fragilis,
defined by V4-16S rRNA analysis of fecal samples obtained at the
time of killing, was significantly greater in mice colonized with the
stunted/underweight donor’s microbiota than inmice colonized with
the healthy donor’s microbiota (P = 1.9 × 10−6, two-tailed Student’s
t test; Fig. 1B).
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Fig. 1. Intact uncultured human fecal micro-
biota and derived culture collections from
healthy and undernourished Bangladeshi
children transmit discordant weight pheno-
types to gnotobiotic mice. (A) Germfree male
C57BL/6 mice (8 to 9 weeks old) (n = 8 per treat-
ment group) gavaged with intact uncultured
fecal microbiota from Bangladeshi donors were
fed a sequence of three embodiments of a repre-
sentative Bangladeshi diet consumed by mem-
bers of the donor population. See fig. S1A for
experimental design. Mean weights (±SEM) as a
function of dpg are shown as percentages of
weights immediately before fecal microbiota
transplantation. (B) Efficiency of capture of bacte-
rial OTUs present in the donor’s intact uncultured
fecal samples in gnotobiotic mice. Mean relative
abundances (±SEM) of 97% ID OTUs representing
≥1% of the total fecal microbial communities in
recipient animals. Results are based on V4-16S
rRNA data sets and summarized at the species
level (or genus when species could not be deter-
mined). OTUs present at lower abundances are
not shown and account for the proportion not
represented in each stacked barplot. (C) Trans-
plantation of culture collections (dashed lines)
generated from the fecal microbiota of the healthy
or stunted/underweight donors recapitulated the
discordant weight phenotype seen with the cor-
responding intact uncultured microbiota (solid
lines) (n = 6 mice per treatment group, mean
weights ± SEM plotted). *P < 0.05 (paired two-
tailed Student’s t test and linear mixed-effects
model, as above). (D) The weight-loss phenotype
observed in recipients of the stunted/underweight
donor’s culture collection is not significantly differ-
ent between the three Bangladeshi diet embodi-
ments tested (P > 0.05; two-tailed Student’s t test).
Mean weights (±SEM) are plotted as a function of
dpg (n = 6 mice per culture collection per diet em-
bodiment). Significant weight differences were
seen between mice colonized with the healthy
donor’s compared to the stunted/underweight
donor’s culture collection in the context of all three embodiments of the Bangladeshi diet. *P < 0.05 (paired two-tailed Student’s t test and linear mixed effects model).
(E) Intergenerational transmission of discordant weight phenotypes. See fig. S1C for experimental design. Mean weights (±SEM) of offspring of female gnotobiotic mice
colonized with the indicated donors’ microbiota (n = 3 to 4 mice per treatment group) are plotted as a function of age. Animals were switched from a nutrient sufficient
LF/HPP mouse chow to embodiments of the Bangladeshi diets beginning on postnatal day 56. *P < 0.05 (tested by both paired two-tailed Student’s t test comparing weights
at killing and linear mixed effects model assessing interaction of weight, dpg, and microbiota through the experiment). The efficiency of intergenerational transmission of 97%
ID OTUs was 96 ± 1.8% and 88 ± 2.3% (mean ± SEM) for the healthy and stunted/underweight donor’s microbiota, respectively (defined at the time of killing).
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Bacterial culture collections from donor fecal microbiota
transmit contrasting weight phenotypes
We next cultured bacterial strains from the healthy and stunted/
underweight donors’ fecal samples (20, 21). Each collection of cultured
strains was clonally arrayed in multiwell plates so each well contained
a monoculture of a given bacterial isolate (20). Each culture collection
consisted of organisms that had coexisted in the donor’s gut and thus
were the products of the donor’s history of environmental exposures
to various microbial reservoirs (including those of family members
and various enteropathogens endemic to the Mirpur thana), as well
as the selective pressures and evolutionary events placed on and operat-
ing within their microbiota (for example, immune, antibiotic, dietary,
and horizontal gene transfer). Individual isolates in the clonally arrayed
culture collection were grouped into “strains” if they shared an overall
level of nucleotide sequence identity of >96% across their assembled
draft genomes (21). On the basis of this criterion and the results of
sequencing amplicons generated from the isolates’ 16S rRNA genes,
we determined that the healthy and stunted donors’ culture collections
contained 53 and 37 strains, respectively. Only one strain was shared
between the two culture collections: Bifidobacterium breve hVEW9
[see table S4 for a list of all isolates in the culture collection derived from
the stunted/underweight child and (21) for details of the healthy donor’s
culture collection]. The two B. fragilis strains present in the healthy
donor’s culture collection (hVEW46 and hVEW47) lacked a BfPAI
and were therefore classified as NTBF. The stunted donor’s collection
contained a single B. fragilis strain (mVEW4) with a bft-3 allele. ETBF
strains of this type are globally distributed but most common in South-
east Asia (22) (see table S5 for a comparison of the functions encoded by
genes in the genomes of these ETBF andNTBF strains and the reference
B. fragilis type strain ATCC 25285).
To ascertain whether the contrasting weight phenotypes conferred
by the two intact uncultured fecal microbiota samples could be
transmitted by the strains captured in their derivative culture collec-
tions, we colonized 8-week-old adult male germfree C57BL/6mice with
all members of either of these two culture collections (n = 6 singly caged
mice per collection; all mice receiving a given culture collection were
maintained in a single gnotobiotic isolator). As a reference control for
this experiment, and to compare results between this and the previous
experiment, we colonized mice with the corresponding intact un-
cultured fecal microbiota samples, housing these mice in separate
isolators from those used for the culture collection transplants. All
mice were fed three embodiments of the Bangladeshi diet (1 week
per diet) in the same order described for the previous experiment. As
with the intact uncultured microbiota, the corresponding culture
collections transmitted discordant weight phenotypes to recipient
animals (P < 0.002, two-tailed Student’s t test, comparison of final
weights; Fig. 1C). Moreover, the weight phenotypes (change in body
weight over time as a percentage of initial weight before gavage) ob-
served with each intact uncultured fecal microbiota and the cor-
responding derivative culture collection were not significantly
different (P > 0.05 for both microbiota donors, two-tailed Student’s
t test; Fig. 1C). The difference in weight phenotypes first became sta-
tistically significant between the two groups of mice midway through
consumption of diet embodiment 2, continued to increase with diet
embodiment 3 (Fig. 1C), and againwere not attributable to differences
in food consumption.
Effect of diet.
To test whether theweight loss phenotypewas sensitive or robust to diet
embodiment type, we gavaged the two clonally arrayed bacterial culture
collections into separate groups of 8-week-old adult male germfree
C57BL/6 mice who were monotonously fed Bangladeshi diet em-
bodiment 1, 2, or 3 for 3 weeks (n = 6 singly caged recipient mice
per culture collection per diet embodiment; fig. S1B). The discordant
weight phenotype observed previously was preserved irrespective of
the Bangladeshi diet embodiment consumed (P < 0.01, two-tailed
Student’s t test, comparison of final weights of mice regardless of diet
embodiment consumed; n = 18 mice per culture collection; Fig. 1D).
Moreover, no significant differences in weights were noted between
groups of mice colonized with the same culture collection but fed
different diet embodiments (P > 0.05 for embodiments 1 versus 2, 1 ver-
sus 3, and 2 versus 3; two-tailed Student’s t test, comparison of final
weights; Fig. 1D).
Transmission of strains was assessed by short-read shotgun sequenc-
ing of DNA isolated from fecal samples collected at the end of the ex-
periment. This method, known as community profiling by sequencing
(COPRO-Seq) (21), maps reads onto the draft genome assemblies of
community members. At the depth of sequencing used [354,352 ±
23,216 (mean ± SEM), 50-nucleotide (nt) unidirectional reads/fecal
DNAsample], we could reliably detect strainswhose relative abundance
is≥0.1%. COPRO-Seq demonstrated that transplantation of the culture
collections was efficient and reproducible, with 98.1 ± 0.6% and 94.5 ±
1.6% (mean ± SEM) of strains in the collections derived from the
healthy and stunted donors, respectively, appearing in recipient
animals. The relative abundance of ETBF in the fecalmicrobiota ofmice
containing the stunted/underweight donor’s culture collection was sig-
nificantly greater than the cumulative relative abundance of the two
NTBF strains in recipients of the healthy culture collection irrespective
of the diet embodiment consumed (75.5 ± 4.1% versus 17.0 ± 4.4%; P =
2.8 × 10−9, two-tailed Student’s t test; Fig. 2A). The relative abundances
of the ETBF strain in recipients of the stunted/underweight donor’s
culture collection, the two NTBF strains in the healthy donor’s collec-
tion, and all other Bacteroides species did not differ significantly be-
tween diet embodiments [P > 0.2 for all Bacteroides, one-way analysis
of variance (ANOVA); Fig. 2B].
Intergenerational transmission of weight phenotypes.
To assess whether this weight loss phenotype was transmissible across
generations of mice, two C57BL/6 male mice from the transplant ex-
periment, one containing the stunted/underweight donor’s culture
collection and the other containing the healthy donor’s collection,
were switched to and subsequently maintained on an irradiated nutri-
tionally enhanced mouse breeder chow from 21 to 48 dpg, at which
time they were each cohoused with two germfree 6-week-old female
mice that had received breeder chow since weaning. Seven days after
cohousing, each male mouse was withdrawn from each mating trio,
and the female mice were subsequently maintained on breeder chow
throughout their pregnancy and as their pups completed the suckling
period (fig. S1C). Male pups (n = 3 to 4 per litter) were then weaned
onto an irradiated, nutritionally sufficient, LF/HPP chow, until they
were 9 weeks old, at which time they were switched to the Bangladeshi
diets (10 days per diet; same order of sequential presentation of the
embodiments as before). Mice born to mothers colonized with either
of these arrayed culture collections experienced identical weight gain
profiles while consuming the LF/HPP diet (P = 0.9, two-tailed Stu-
dent’s t test; table S6). However, once they were transitioned to the
sequence of three Bangladeshi diet embodiments (consumed from
postnatal days 56 to 86), mice born to mothers harboring a stunted/
underweight donor’s microbial community exhibited significantly
greater weight loss (P = 0.03, two-tailed Student’s t test comparing
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weights at killing). The total relative abundance of the two NTBF
strains in fecal samples obtained from recipients of the healthy donor’s
culture collection was 4.2 ± 0.7% at the conclusion of the LF/HPP diet
period and 4.6 ± 0.9% at the conclusion of the Bangladeshi diet
embodiment sequence, whereas the relative abundance of ETBF at
these two time points was 34.3 ± 4.2% and 50.0 ± 0.7%, respectively,
in mice colonized with the stunted/underweight donor’s culture
collection.
An independent intergenerational transfer experiment was per-
formed, in this case using the donors’ intact uncultured fecal mi-
crobiota. The efficiency of ETBF and NTBF transmission from
mothers to pups was 100%. As with the culture collections, there
was diet-dependent transmission of the discordant weight loss phe-
notype (Fig. 1E; compare with Fig. 1A).
Microbial community context determines the effects of ETBF
on community members and host
To establish whether ETBF is necessary and sufficient to cause
marked weight loss in multiple community contexts, we performed
a series of manipulations that involved removing the ETBF strain
from the stunted/underweight donor’s culture collection and add-
ing it to the healthy donor’s culture collection, with or without sub-
traction of its two NTBF strains (Fig. 2C). These manipulations
allowed us to characterize (i) the role of community context in deter-
mining ETBF pathogenicity, (ii) the community/host responses to
ETBF, (iii) the ability of NTBF to modulate ETBF effects, and (iv)
the effects of ETBF on NTBF. Recipient C57BL/6 male mice in each
of the different treatment groups were 8 to 9 weeks old at the time of
colonization; all were placed on diet embodiment 2 for 2 days before
Fig. 2. ETBF is necessary but not sufficient to
produce weight loss in recipient gnotobiotic
mice. (A) Gut microbial community composi-
tion, defined by COPRO-Seq, in mice colonized
with either of the two unmanipulated culture
collections or the derived manipulated ver-
sions. Mean values for relative abundances ±
SEM are plotted using aggregate data gener-
ated from fecal samples collected from mice
colonized with a given community. Taxa pres-
ent at abundances lower than 1% are not rep-
resented in the stacked barplots. (B) The
proportional representation of Bacteroides taxa
in unmanipulated culture collections installed
in gnotobiotic mice does not differ significantly
as a function of the diet embodiments animals
were fed. Means ± SEM for data generated from
feces are shown (n = 5 to 6 per group; one-way
ANOVA). (C) Schematic illustrating the different
groups of gnotobiotic mice generated by ma-
nipulating the presence/absence of ETBF and
NTBF within the stunted/underweight or healthy
donors’ culture collections and the questions ad-
dressed by the indicated comparisons. (D) Re-
moval of ETBF prevents weight loss in mice
colonized with the stunted/underweight donor’s
culture collection. In contrast, addition of ETBF
with the simultaneous removal of NTBF does
not significantly affect weight in mice colonized
with the culture collection derived from the
healthy child (n = 5 to 6 mice per treatment
group). Means ± SEM are plotted. *P < 0.05
(paired two-tailed Student’s t test and linear
mixed effects model as above). (E) Addition of
NTBF to the stunted/underweight donor’s culture
collection ameliorates ETBF-associated weight
loss in gnotobiotic mice fed embodiment 2 of
a representative Bangladeshi diet (n = 6 mice
per treatment group). Means ± SEM are plotted.
*P < 0.05 (paired two-tailed Student’s t test and
linear mixed effects model as above).
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gavage and subsequently maintained on this diet for 14 days until they
were killed (n = 5 singly caged animals per treatment group, main-
tained in separate gnotobiotic isolators). Fecal samples were collected
at the time points described in fig. S1D.
Weight phenotypes.
Removal of the ETBF strain from the stunted/underweight donor’s
culture collection prevented the transmissible weight loss phenotype
(Fig. 2D; P = 5.9 × 10−8, two-tailed Student’s t test, comparison of
weights at killing). However, addition of the ETBF strain to the healthy
donor’s culture collection did not produce significant weight loss, re-
gardless of whether the NTBF strains were present or absent (P = 0.3
and P = 0.2, respectively, two-tailed Student’s t test, comparison of
weights at killing; Fig. 2D). On the basis of these findings, we concluded
thatwhether ETBF producesweight loss (cachexia) is dependent onmi-
crobial community context.
COPRO-Seq analysis of the fecal microbiota of recipients of the un-
manipulated ETBF(−) NTBF(+) healthy donor’s culture collection re-
vealed that it contained the two NTBF strains [total relative abundance
of 14.5 ± 3.0% (mean ± SEM), with B. fragilis hVEW46 and B. fragilis
hVEW47 comprising 1.1 and 13.5%, respectively], two otherBacteroides
(B. thetaiotaomicron and B. caccae), plus Bifidobacterium breve and
Enterococcus. The relative abundance of B. fragiliswas not significantly
different between mice harboring the transplanted unmanipulated
healthy donor’s culture collection and its two manipulated ETBF(+)
NTBF(−) and ETBF(+) NTBF(+) versions (P > 0.5, two-tailed Stu-
dent’s t test; Fig. 2A). (The term “unmanipulated” indicates that all bac-
terial isolates that comprise a culture collection were pooled before
transplantation, whereas “manipulated” refers to the inclusion and/
or exclusion of B. fragilis strains as part of the gavaged consortium.)
The fecalmicrobiota of recipients of the unmanipulated stunted donor’s
culture collection was dominated by ETBF (relative abundance, 62.3 ±
4.0%). Removal of ETBF led to significant increases in the relative abun-
dances of B. breve, another Bifidobacterium strain, Enterococcus lactis, and
Enterococcus gallinarum (P < 0.02, two-tailed Student’s t test; Fig. 2A).
To determinewhether NTBF alone is sufficient to protectmice from
ETBF’s cachectic effects, we colonized three groups of C57BL/6 male
gnotobiotic mice, each with a different version of the stunted donor’s
culture collection: the unmanipulated culture collection containing
ETBF alone or one of two manipulated versions, one with NTBF alone,
and the other with both ETBF and NTBF strains. Mice were placed on
diet embodiment 2 for 2 days before gavage andmaintained on this diet
for 2 weeks until killed (n = 6 animals per treatment group, all singly
caged; one treatment group per gnotobiotic isolator; fig. S1D). We ob-
served a significant difference in weight phenotypes between mice co-
lonized with the unmanipulated undernourished donor’s ETBF(+)
NTBF(−) culture collection compared to the manipulated ETBF(−)
NTBF(+) version (P=0.01, one-tailed Student’s t test; Fig. 2E). Addition
of NTBF [yielding the ETBF(+) NTBF(+) community] markedly ame-
liorated the weight loss phenotype (P = 0.0004 for weights at killing
compared to mice with the unmanipulated community, one-tailed Stu-
dent’s t test; Fig. 2E). Follow-up COPRO-Seq analysis revealed that the
relative abundances of ETBF at the conclusion of the experiment were
38.9 ± 3.9% and 39.0 ± 3.5% when animals were colonized with and
without NTBF, respectively. Thus, NTBF does not appear to mediate
its effects by reducing the fractional representation of ETBF in the com-
munity. However, ETBF appears to reduce the relative abundance of
NTBF, which constituted 41.8 ± 3.2% of the total community when
ETBF was absent but only 19.2 ± 2.6% when ETBF was present (P =
0.04, one-tailed Student’s t test).
The effects of intraspecific interactions on microbial
gene expression.
Weperformedmicrobial RNA sequencing (RNA-seq) of cecal contents
harvested at killing to characterize the transcriptomes ofmembers of the
unmanipulated and manipulated versions of the healthy and stunted
communities. Our goal was to assess (i) the effects of intraspecific com-
petition (NTBF on ETBF and vice versa) in the healthy and stunted
community contexts, (ii) the effects of the cultured stunted/underweight
versus healthy donor community on ETBF, and (iii) the effects of
cocolonization with ETBF on other bacterial members (including other
Bacteroides). ETBF genes with significant differential expression attrib-
utable to the presence or absence of NTBF, in both healthy and stunted
community contexts, are listed in table S8 (B and F). Conversely, NTBF
geneswith significant differential expression attributable to the presence
or absence of ETBF, in both healthy and stunted community contexts,
are highlighted in table S8 (C and E).
Fragipain is a cysteine protease that activates fragilysin by removing
its autoinhibitory prodomain. Inmousemodels of colitis, host proteases
can also serve this function, but fragipain is required for sepsis to occur
(23, 24). In the presence of NTBF, ETBF expression of fragilysin (bft-3)
in the cecal metatranscriptome of mice harboring the manipulated
ETBF(+) NTBF(+) healthy donor’s community was significantly de-
creased compared to the manipulated version of the community where
ETBF, but not NTBF, was present (39-fold, based on normalized
transcript counts; P = 0.002, one-tailed Student’s t test). Fragipain ex-
pressionwas also significantly reduced (14.2-fold;P= 0.0005, one-tailed
Student’s t test) (table S8B). In the context of the stunted community, the
reduction in bft-3 expression associated with introducing NTBF was
considerablymoremodest (5.9-fold;P= 0.09, one-tailed Student’s t test),
whereas fragipain expression was not significantly different between the
two treatment groups (P > 0.5, one-tailed Student’s t test; table S8).
When we abrogated fragilysin (bft-3) expression through insertional
mutagenesis (fig. S2), the mutant Dbft-3 strain grew robustly in vitro.
However, when germfree mice were gavaged with a manipulated ver-
sion of the stunted donor’s culture collection containing this isogenic
strain with a disrupted bft-3 locus substituted for the wild-type ETBF
strain, we observed no detectable colonization of themutant (n= 5mice
fed diet embodiment 2 for 14 days); the number of COPRO-Seq reads
mapping to the mutant Dbft-3 strain was no greater than background,
and a PCR assay that used B. fragilis–specific bft primers was negative.
However, these results led us to conclude that this locus functions as
an important colonization factor for this particular ETBF strain in this
community context. However, these experiments did not allow us to
directly address the hypothesis that attenuation of bft-3 expression
produced by inclusion ofNTBF in the stunted community contributed
to the observed mitigation of weight loss.
Looking beyond the effects of intraspecific interactions on btf-3 ex-
pression, we compared the cecal metatranscriptomes of gnotobiotic
mice colonized with the unmanipulated NTBF(+) ETBF(−) healthy
donor’s culture collection versus mice harboring the two manipulated
versions where ETBF was added, with or without removal of the two
NTBF strains. The results revealed that ETBF in the absence of NTBF
produced significant alterations in the expression of a number of tran-
scripts related to various features of stress responses in several commu-
nity members [Enterococcus faecalis, E. gallinarum, B. breve, and two
members of Enterobacteriaceae; differentially expressed genes identified
using the Robinson and Smyth exact negative binomial test (25), with
Bonferroni correction for multiple hypotheses] (Fig. 3). Both rpoS,
which is a key general stress response sigma factor that positively
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controls expression of genes involved in transport of carbon sources and
iron acquisition, and recD, which is involved in DNA repair, exhibited
significant increases in their expression in the setting of ETBF without
NTBF (P < 0.05). Several genes involved in the acquisition and metab-
olism of iron were either up-regulated in the presence of ETBF (for ex-
ample, ferric aerobactin receptor, ferric uptake regulation protein, and
aerobactin synthase) or repressed (for example, an Enterobacteriaceae
strain hVEW34 homolog of the Escherichia coli BasSR system com-
ponent BasS, which is normally induced under high-iron conditions)
(26). ETBF’s effect on expression of these latter genes was mitigated
when NTBF was present (Fig. 3), highlighting the importance of iron
in intraspecific and interspecific interactions in the healthy donor’s con-
sortium of transplanted cultured bacterial strains. In contrast, the pres-
ence or absence of ETBF or NTBF did not evoke significant changes in
the expression of these or other genes involved in iron metabolism in
the context of the stunted/underweight donor’s community. Numerous
genes related to prophage and mobile DNA element biology were also
expressed at significantly higher levels by healthy community members
when ETBF was present in the absence of NTBF (P < 0.05; Fig. 3). Pro-
phage activation occurs in response to stress. Some studies have postu-
lated that phage induction can “shuffle” community structure to favor
an increased proportion of pathobionts (27).
Studies in gnotobiotic mice have shown that signaling by members
of the human gut microbiota involving the quorum sensing molecule,
autoinducer-2 (AI-2), can alter virulence factor expression in enter-
opathogens (28) and have linked AI-2 signaling to modulation of the
levels of Bacteroidetes in the gut (29). LuxQ is involved in the detection
of AI-2. In the context of the healthy community, expression of three of
the four luxQ homologs in the ETBF genome was decreased when
NTBF was present [log2(fold change) of −2.8, −4.4, and −9.5, P <
0.005, exact negative binomial test; table S8B]. Comparing the mice
colonizedwith the unmanipulated ETBF(−)NTBF(+) andmanipulated
ETBF(+) NTBF(+) versions of the healthy donor’s culture collection
revealed differential regulation of five other luxQ transcripts encoded by
Bacteroidesmembers (three in B. thetaiotaomicron hVEW3, and two in
B. caccae hVEW51; table S8D). In the context of the stunted donor’s
community, the presence of ETBF had no significant effects on lux gene
expression in NTBF or any other community members, nor did the
presence ofNTBFhave any effect on lux expression in ETBF (table S8, E
and F). Together, these results illustrate the importance of community
context in determining the transcriptional effects of intraspecific (and
interspecific) interactions involving ETBF.
Metabolism.
The metabolic effects of manipulating the representation of ETBF and
NTBF in the healthy and stunted donor’s communities were studied by
targeted mass spectrometry (MS) of tissue samples obtained frommice
in the fed state (table S7). Quantifying amino acids, organic acids, acyl-
carnitines, and acyl-CoAs in livers obtained from animals colonized
with either of the two unmanipulated culture collections disclosed that
compared to mice harboring the healthy donor’s ETBF(−) NTBF(+)
culture collection, those colonized with the stunted donor’s ETBF(+)
NTBF(−) culture collection had higher concentrations of propionyl-
CoA and isovaleryl-CoA [by-products of oxidation of branched-chain
and other amino acids; P < 0.05, false discovery rate (FDR)–adjusted
two-tailed Student’s t test; Fig. 4A], and lower concentrations of acetyl-
CoA (P = 0.07) and its cognate metabolite acetyl carnitine (that is, C2
acylcarnitine; P = 0.001; Fig. 4B). Mirroring these trends, cecal contents
harvested at the time of killing frommice harboring the stunted donor’s
unmanipulated culture collection contained higher concentrations of
branched-chain amino acids (P = 0.066 for isoleucine/leucine and P =
0.1 for valine) and lower concentrations of acetyl-carnitine (P = 0.067).
However, these trends were not observed in skeletal muscle.
Acetyl-CoA and acetyl-carnitine are generated by glucose, fatty acid,
or amino acid metabolism, with a primary contribution from glucose
metabolism in the fed state. A deficit in these metabolite pools suggests
impaired fluxof glucose to acetyl-CoA inmicewith the stunted compared
to healthy donor’s unmanipulated culture collection. The decline in acetyl-
CoA and acetyl-carnitine levels occurred in concert with significant
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Fig. 3. The effects of intraspecific NTBF-ETBF interactions on the community
metatranscriptome. Adult mice were colonized with the indicated unmanipulated
and manipulated versions of the healthy donor’s culture collection. All treatment
groups were monotonously fed diet embodiment 2. Cecal contents were collected
at the time of killing 14 days after initial colonization, and gene expression in the com-
munity was analyzed by microbial RNA-Seq. Each column represents data from an in-
dividual mouse. Each row represents the levels of a given transcript, normalized across
that row. Addition of ETBF to and removal of NTBF from the healthy donor’s culture
collection (middle set of columns) produced an increase in expression of the indicated
genes in strains whose identity is denoted by the color code on the left, compared to
their expression in the unmanipulated ETBF(−) NTBF(+) version (left set of columns) or
the manipulated version where the NTBF strains were retained when ETBF was added
(right set of columns). UniProt-basedannotations are shownon the right. ATP, adenosine
triphosphate; HTH, helix-turn-helix.
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increases in hepatic levels of the late tricarboxylic acid (TCA) cycle
intermediates malate and fumarate (P < 0.005 compared to mice with
the healthy donor’s culture collection; Fig. 4C), as well as a trend toward
increased succinate (P = 0.1). These patterns were againmirrored in the
cecum but not in skeletal muscle. Early-stage TCA cycle intermediates
citrate and a-ketoglutarate were not different across these groups. Con-
versely, and consistent with impaired glucose availability or metabo-
lism, lactate concentrations were significantly lower in the livers of
mice colonized with the stunted donor’s culture collection (P = 0.002;
Fig. 4C), with an associated decrease in cecal lactate concentrations (P=
0.0005; table S7B).Hepatic pyruvate also showed a downtrend (P=0.16;
table S7B).
Combining the acyl-CoA and organic acid data, this metabolic
profile is consistent with a scenario in which mice colonized with the
unmanipulated ETBF-containing stunted donor’s culture collection
have decreased capacity for metabolism of glucose to acetyl-CoA. It
appears that these animals attempt to compensate by an increase in
amino acid metabolism that is sufficient to produce enough acetyl-
CoA to maintain normal citrate and a-ketoglutarate levels. However,
use of these fuels also creates substrates that lead to production of distal
TCA cycle intermediates (anaplerosis), for example, via propionyl-CoA
conversion to succinate, and aspartate conversion to oxaloacetate, fu-
marate, and malate.
Comparingmice colonized with the unmanipulated stunted donor’s
culture collection versus the manipulated ETBF(−) NTBF(−) version of
the stunted donor’s culture collection revealed that removal of ETBF
was not sufficient to reverse themetabolic
abnormalities described above. ETBF re-
moval produced a significant reduction in
hepatic levels of d18:1/16:0 ceramide, a
known inhibitor ofmitochondrial electron
transport complex IV (P = 0.02; Fig. 4D)
and consistent with decreased oxidative
metabolism. Ceramides are involved in
key intracellular stress response pathways,
including those associated with immu-
noinflammatory responses. This effect
was strain-specific: NTBF alone did not
produce the same result in mice colo-
nized with the manipulated ETBF(−)
NTBF(+) version of the stunted donor’s
culture collection. Moreover, the ETBF-
associated elevation in d18:1/16:0 was
prevented by the presence of NTBF [P =
0.007, FDR-adjusted two-tailed Student’s
t test, comparison of mice colonized with
the unmanipulated stunted community
versus the manipulated ETBF(+) NTBF(+)
community].
Gut barrier/immune function.
One view of the effects of B. fragilis en-
terotoxin is that it perturbs gut barrier
function, increasing permeability via
cleavage of E-cadherin (11), triggering
the release of proinflammatory cytokines
including tumornecrosis factor–a (TNF-a)
(30), and augmenting b-catenin signaling
(31). Treatment of chow-fed, convention-
ally raised mice with antibiotics followed
by introduction of wild-typeNTBF, NTBFwith an engineered active bft
allele, wild-type ETBF with an active bft allele, or ETBF with a Dbft1
allele revealed that under these conditions, bftwas necessary to produce
colitis (32). Small-scale human studies have demonstrated a greater
representation of ETBF in individuals with active inflammatory
bowel disease (33) and colorectal cancer (34). Strains harboring bft-3
have been reported to generate less biologically active toxin than strains
having bft-1 or bft-2 alleles (22).
Analyses of hematoxylin and eosin–stained sections of small intes-
tine and colon obtained from mice consuming the representative
Bangladeshi diet and colonized with either of the two unmanipulated
culture collections or two manipulated versions [ETBF(−) NTBF(−)
stunted or ETBF(+)NTBF(+) healthy] revealed no hallmarks of inflam-
mation, such as an overabundance of neutrophils in the gut mucosa,
crypt hyperproliferation or loss, or loss/damage of villi in the small in-
testine (n = 5 mice examined per treatment group).
We performed a follow-up flow cytometry analysis of immune cell
populations in the colon, and mesenteric lymph nodes of four groups
of mice: those colonized with the stunted donor’s culture collection
with or without ETBF and those harboring the unmanipulated
healthy donor’s culture collection or its manipulated ETBF(+) NTBF(−)
version. Consistent with a previous study of specified pathogen-free
mice treated with antibiotics to boost colonization with an ETBF isolate
(34), colonic T helper 17 (TH17) cell populations (TCR-b
+CD4+CD8a−
IL-17A+) were significantly increased in animals colonized with ma-
nipulated ETBF(+) NTBF(−) healthy and unmanipulated ETBF(+)
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Fig. 4. Host metabolic abnormalities associated with the stunted donor’s community. Mice were colonized with
the indicated culture collections and feddiet embodiment 2. Animalswere killed 21days after colonization, andmetabolites
in their liverswere quantified bymass spectrometry (n=5 to 6mice per treatment group). Means± SEMare plotted. Altered
concentrations of acyl-CoAs (A), acylcarnitines (B), andorganic acids (C) in the livers ofmice colonizedwith the unmanipulated
ETBF(+) NTBF(−) stunted donor’s culture collection versus animals harboring the unmanipulated ETBF(−) NTBF(+) healthy
donor’s culture collection provide evidence for metabolic dysfunction involving the TCA cycle andmitochondrial fatty acid
oxidation in the former group. (D) ETBF in the setting of the unmanipulated stunted donor’s community is associated with
greater hepatic concentrations of the d18:1/16:0 ceramide known to inhibitmitochondrial oxidativemetabolism compared
to manipulated versions of the culture collection where ETBF has been removed with or without replacement by NTBF or
when NTBF and ETBF are both present. *P < 0.05 (two-tailed Student’s t test).
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NTBF(−) stunted culture collections compared to the unmanipulated
ETBF(−) NTBF(+) healthy and manipulated ETBF(−) NTBF(−)
stunted culture collections (P < 0.001 and P < 0.02, respectively, Stu-
dent’s t test; fig. S3, A and B). The presence of ETBF was not associated
with significant differences in the size of the anti-inflammatory FoxP3+
regulatory T cell population in mesenteric lymph nodes in either the
stunted/underweight or healthy community contexts (P> 0.05, Student’s
t test; fig. S3C).
B. fragilis polysaccharide A (PSA) is the product of one of the orga-
nism’s capsular polysaccharide synthesis (CPS) loci. A number of studies
have shown that PSA functions as an immunomodulatory factormitigat-
ing inflammatory responses in the gut via its effects on reducing interleukin-
17 (IL-17) and inducing FoxP3+ regulatory T cells (35, 36). Microbial
RNA-seq disclosed that the expression of genes in this CPS locus (37)
wasnot significantly different in theETBFandNTBF strains as a function
of community context (unmanipulated versions of the healthy or stunted
donor consortia) or engineered intraspecific interactions (table S8B).
We expanded our analysis to examine the effects of intraspecific
interactions on serum cytokine profiles in three groups of mice: those
harboring the unmanipulated stunted donor’s culture collection and
those colonized with the manipulated ETBF(+) NTBF(+) and EBTF(−)
NTBF(+) versions. ETBF(+) NTBF(−) mice had significantly higher
levels of the proinflammatory cytokines IL-17A, TNF-a, and interferon-g
compared to ETBF(−) NTBF(+) mice (P = 0.02, P = 0.03, and P = 0.03,
respectively; one-tailed Student’s t test) (fig. S3D). However, these effects
were not reversed with NTBF cocolonization (P > 0.05 for all compar-
isons) despiteNTBF’s protective effect with respect toweight loss, leading
us to postulate that (i) theweight loss phenotypewas a reflection, at least
in part, of the combined effects of disturbances in central metabolism
and subtle perturbations in gut barrier function, and (ii) othermembers
of the undernourished donor’s transplanted culture collection, besides
ETBF, were contributors to these abnormalities.
DISCUSSION
The question of what determines the effects of a large enteropathogen
burden in children at risk for undernutrition, or with already overt
disease, is rooted in the definition of “pathogen”—both conceptually
and operationally. Koch’s postulates invoke the requirement for an
isolated candidate pathogen to produce a disease when introduced into
a host species, without necessarily considering the microbial ecology of
the body habitat that the organism invades and establishes itself. The
approach described in this study, involving generation of sequenced,
clonally arrayed culture collections from the fecal microbiota of healthy
and stunted/underweight Bangladeshi children and subsequent intro-
duction of these consortia, with or without addition or subtraction of
ETBF and NTBF strains, into germfree mice fed embodiments of the
diets consumed by the microbiota donors, allowed us to characterize
how B. fragilis functions as a pathobiont in a microbial community
context-dependent manner.
A topic of interest to those studying the pathogenesis of under-
nutrition is the relative effects of enteropathogen burden in nondiar-
rheal fecal samples and the presence or absence of environmental
enteric dysfunction, an enigmatic disorder associated with populations
where sanitation is poor and enteropathogen burden is high (38). Al-
though ETBF itself was not correlated with stunting in our small study
cohort of 100 children, additional studies in larger populations coupled
with quantitative PCR assays for other enterpathogens are needed to
ascertain the contributions of ETBF to disease. Results from our gnoto-
biotic mouse studies emphasize that microbiota community context
also needs to be considered when understanding the potential effects
of this and other enteropathogens (39). The approach described in
this report should help shed light on this issue. Constructing commu-
nities from culture collections captures a donor’s history of microbial
exposures in their places of residency, as well as the evolutionary events
that have shaped the genetic features of the gut strains they harbor.
Culture collections generated from healthy and undernourished donors
from this or other populations can be introduced into young rapidly
growing animals (either through direct gavage or maternal transmis-
sion), or into adult animals, to better understand how intraspecific
and interspecific interactions with one or more enteropathogens affect
host biology in specified and/or systematically manipulated dietary and
microbial community settings. A limitation of the present study is that
themicrobiota dissectionwas limited to two donors from a small cohort
of 100 children. An obvious next step is to address the generalizability of
our findings; this can be accomplished in a variety of ways, including
analyses of the effects of introducing different ETBF and NTBF strains
recovered from other Bangladeshi donors into the existing culture
collections, aswell as culture collections generated from individuals rep-
resenting other populations.
An intriguing difference transmitted by the healthy and under-
nourished donor’s culture collections involves the host metabolic
phenotype. On the basis of our findings, we propose that the limited
rate of acetyl-CoA production in mice receiving the stunted donor’s
culture collection cannot keep pace with the increased influx of sub-
strates that replenish TCA cycle intermediates (anaplerosis), explaining
the increase in distal TCA cycle substrates. At a more global level,
increased oxidation of amino acids to maintain a minimal acetyl-CoA
pool may divert amino acids away from protein synthesis, contributing
to a wasting phenotype. Furthermore, concentrations of amino acids
were modestly but consistently lower in the sera of mice colonized with
the culture collection from the stunted compared to the healthy donor.
This is consistent with use of amino acids for anaplerosis, thereby con-
tributing to lower amino acid supplies for host growth andmetabolism.
Some bacterial members of the gut microbiota contain the complete
enzymatic apparatus for executing the TCA reaction sequence. The
finding that there is marked inhibition of the distal TCA cycle in har-
vested cecal contents and liver but not skeletal muscle leads to the fol-
lowing testable hypotheses: (i) interactions between the undernourished
donor’s microbiota and dietary components yield products that are
present at high-enough levels to inhibit the TCA cycle in community
members; (ii) these products are transported from the gut by the portal
circulation in sufficient quantities to inhibit the TCA cycle in hepato-
cytes; (iii) either first-pass metabolism of these products by the liver or
other processes limit their levels in the systemic circulation so that their
effects on the TCA cycle are not observed inmuscle; and (iv) TCA cycle
inhibition negatively affects the ability to harvest energy froman already
impoverished diet.
In our previous study of Malawian twins discordant for severe acute
malnutrition, 1Hnuclearmagnetic resonance analyses of urine obtained
from adult gnotobiotic mice colonized with intact unculturedmicro-
biota indicated that TCA cycle inhibition was a feature of animals
harboring the undernourished co-twin’s microbiota and consuming
a macronutrient- and micronutrient-deficient prototypic Malawian diet.
These animals but not their counterparts that had been colonized with
the healthy co-twin’s microbiota exhibited a pronounced diet-dependent
weight loss phenotype that didnot occur in the context of amacronutrient-
and micronutrient-sufficient diet (7). Together, these findings suggest
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that metabolic studies of serum, urine, and feces obtained from chil-
dren before, during, and after treatment for their undernutrition
should include quantitative assessment of analytes linked to TCA
cycle activity.
MATERIALS AND METHODS
Human study design
Samples were obtained from an already completed observational
birth cohort study (Field Studies of Human Immunity to Amebiasis in
Bangladesh) (14). The study was conducted using protocols for obtain-
ing informed consent, clinical samples, and clinical metadata that were
approved by institutional review boards from the International Centre
for Diarrhoeal Disease Research, Bangladesh (icddr,b) (study ID num-
ber 2007-041), the University of Virginia, Charlottesville (study ID
number 7563), andWashingtonUniversity in St. Louis (study IDnumber
201111065). Fecal specimens used in this study were covered by a
material transfer agreement between icddr,b andWashington University
in St. Louis. Fecal samples from 100 of the 147 children enrolled in this
study were used for the analysis described in the current report; this num-
berwasnot based on aprevious power calculationderived fromknowledge
of ETBF carriage rate but rather represented samples from individuals
who had been surveyed during the second year of postnatal life.
bft PCR assay
DNA isolated from fecal samples collected at 18 and 24 months of age
from members of the birth cohort was used for a bft PCR assay using
primer pairs 5′-GAACCTAAAACGGTATATGT-3′ (GBF-201) and 5′-
GTTGTAGACATCCCACTGGC-3′ (GBF-210) (40), OneTaq 2×Master
Mix (New England Biolabs) and the following thermocycling conditions:
after initial melting at 95°C for 30 s, 30 cycles of 95°C for 30 s, 53°C for
30 s, and 68°C for 30 s, with a final annealing time of 7 min at 68°C.
Testing fecal samples for parasites
A clinical microscopy–based screen for Entamoeba histolytica, Entamoeba
dispar, Blastocystis hominis,Trichomonas hominis, coccidian-like bodies,
Giardia lamblia, Ascaris lumbricoides, Trichuris trichiura, Ancylosto-
ma duodenale/Necator americanus, Hymenolepsis nana, Endolimax
nana, Iodamoeba butschlii, andChilomastixmesniliwas also performed
on these fecal samples, as reported in (5).
Preparation of human fecal samples for transplantation to
germfree mice
Aliquots (1 g) of previously frozen fecal samples were resuspended
under anaerobic conditions (77% N2, 20% CO, and 3%H2) in 15 ml of
gut microbiota medium (GMM) (20) and homogenized at a setting of
“high” in a sterilized blender (Waring). Homogenates were clarified by
passage through 100-mm–pore-diameter nylon filters (BD Falcon). Five
milliliters of sterile 2-mm-diameter glass beads was added, and remain-
ing cell clumps were disrupted by vortexing (four on/off cycles, each for
30 s). A final filtration through a 40-mm–pore-diameter nylon filter (BD
Falcon) was performed before storage in GMM containing glycerol
[final concentration of 15% (v/v)] at −80°C in 2-ml amber glass vials
with a crimp-top butyl septum (Wheaton Scientific).
Preparation of Bangladeshi diet embodiments
Diet embodiments with ingredient and nutritional contents described
in table S2 were prepared in 15-kg batches. Tilapia fish fillets (Whole
Foods Markets) were simmered for 30 min in a 20-liter stainless steel
pot over a Corning hot plate (temperature set at “4”). Fruits and vege-
tables were combined and simmered in a separate pot for 45 min on a
Corning hot plate (temperature set at “4”). Parboiled rice (Delta Star)
was cooked in a rice cooker (KRUPS). Lentils were simmered for 90min
(temperature set at “2”). All ingredients for a given diet embodiment
were combined in a vertical cutter-mixer (Robot Coupe Model R23)
and pureed for 5 min. Aliquots were cooled in large plastic containers
for 12 hours at 4°C. Aliquots (500 g) were then vacuum-sealed in 8 ×
10–inch plastic bags (Uline). The vacuum-sealed food paste was placed
in a second 8 × 10–inch plastic bag (as an added barrier against inciden-
tal contamination), and the contents of the packages were sterilized by
irradiation (20 to 50 kGy) within 24 hours of food production (Steris
Co.). Sterility was verified by culturing samples of the irradiated diet in
brain heart infusion (BHI) medium for 5 days at 37°C under anaerobic
and aerobic conditions (21). In addition, B. subtilis spore strips that had
been included along with the food during the irradiation were cultured
under the same conditions. Final nutritional profiles were obtained for
samples of each embodiment (Nestlé PurinaAnalytical Laboratories, St.
Louis, MO).
Clonally arrayed bacterial culture collections
Collections of cultured anaerobic bacterial strains were generated from
frozen fecal samples according to previously published methods (20, 21).
Cultures were arrayed in 384-well plates in Coy Chambers under strict
anaerobic conditions (77% N2, 20% CO, and 3% H2) using a Precision
XS liquid handling robot (BioTek). Bacteria isolates occupying eachwell
were first grouped into 100% IDOTUs on the basis of the results of V4-
16S rRNA amplicon sequencing. Most OTUs were observedmore than
once across an arrayed library. Next, three to four isolates representing
each OTU were picked robotically from the 384-well arrays and struck
out individually onto eight-well agar plates containing GMM (20).
DNA from isolates was subjected towhole-genome shotgun sequencing
using an Illumina HiSeq 2000 instrument (101-nt paired-end reads) or
aMiSeqmachine (150-nt paired-end reads). Sequences were assembled
using MIRA (41) version 4.02 (parameters: “-NW:cnfs = warn, −NW:
cmrnl = no, −GE:not = 4”; template_size = “150 500 autorefine”). Cov-
erage of isolate genomes from the severely stunted/underweight donor’s
culture collection was 38.6- ± 5.0-fold (mean ± SEM)with anN50 contig
length of 28.5 ± 3.5 kb (mean ± SEM) (table S3B). The corresponding
values for members of the healthy donor’s collection are described in
(21). Genes were annotated using Prokka (v1.10) (42). Predicted genes
in each isolate’s genome assemblies were mapped to KEGG pathways
and assigned KEGGOrtholog groups by querying the KEGG reference
database (release 72.1) (BLAST 2.2.29+, blastpE value≤10−10, single best
hit defined by E value and bit score). Putative virulence factors were iden-
tified using the Virulence Factor Database [(43); BLAST hits with E value
<10−17 bearing UniProt database annotations].
Full-length 16S rRNA gene amplicons were generated from isolates
using primers 8F and 1391R. Isolates sharing≥99% nucleotide sequence
identity in their 16S rRNAgenes and≥96%sequence identity throughout
their genomes as determined byNUCmer (44)were defined as represent-
ing a unique strain. Full-length 16S rRNA sequences were used to define
taxonomy [RibosomalDatabase Project (RDP) version 2.4 classifier (45)].
Clonally arrayed, sequenced culture collections were stored in GMM/15%
glycerol at 80°C in 96-well plates (TPP Tissue Culture Test Plates).
Generation of a bft-3:pGERM mutant in the ETBF strain
cultured from the stunted donor’s microbiota.
Disruption of the bft-3 gene was accomplished using the Bacteroides
suicide vector pGERM. A 380–base pair (bp) fragment of the 5′ end of
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bft-3 was introduced into Bam H1–digested pGERM using the Gibson
Assembly Cloning Kit (New England Biolabs). Primers to create the
PCR product for the Gibson reaction were created using the NEBuilder
Assembly Tool (v1.7.2). Assembled constructs were introduced by elec-
troporation into kanamycin-resistant, electrocompetent E. coli DH5-a
RK231 (46). Transformants were plated on LB agar containing
isopropyl-b-D-thiogalactopyranoside/X-gal (Sigma-Aldrich)andampicil-
lin (100mg/ml). Individual colonies were picked and grown in LBme-
dium plus ampicillin; successful transformation was verified by PCR. The
pGERM-transformedE. coliDH5-aRK231 and the ETBF strain (isolate
mB11 of strain B. fragilismVEW4) were conjugated by filter-mating on
BHI-blood agar plates incubated under anaerobic conditions at 37°C for
24 hours. Bacterial cells from the resulting lawn were collected by
scraping and plated on BHI agar containing erythromycin/gentamicin
(25 and 100 mg/ml, respectively). Plates were incubated under anaerobic
conditions at 37°C for 48 hours. Picked colonies were sequenced to con-
firm successful pGERM insertion into bft-3, and positive colonies were
stored in tryptone yeast glucose (TYG) containing 15% (v/v) glycerol.
The mutant and wild-type strains were cultured at 37°C under
anaerobic conditions in TYG liquid medium to mid-log phase. Cells
were then harvested, and RNAwas extracted using TRIzol reagent (Life
Technologies). To confirm that bft expression had been disrupted,
complementary DNA (cDNA) was generated from the extracted RNA
(see RNA-seq section below) and used as a template for a PCR-based
assay that used ReddyMix PCRMaster Mix (Thermo Fisher Scientific),
a forward primer that spans the vector insertion site (5′-ATGAA-
GAATGTAAAGTTACTTTTAATGCTAGGAACCG-3′), a reverse
primer 3′ to the crossover site (5′-CTCCACTTTGTACTTTATAC-
TACTGAATATGCTTG-3′), and the following cycling conditions:
94°C for 10 min followed by 30 cycles of 94°C for 30 s, 56°C for 30 s,
72°C for 60 s, with a final extension of 72°C for 5 min.
Assembling consortia of cultured bacterial strains
for gavage
Archived 96-well culture collection plates were thawed in an anaerobic
chamber and aliquots of each well inoculated into 600 ml of GMM in
96-deep-well culture plates (Thermo Fisher Scientific). Cultures
were grown anaerobically to stationary phase at 37°C, with growth
measured at OD600 (optical density at 600 nm). Equal amounts of
selected isolates (100 ml) were pooled using the Precision XS liquid
handling robot. Formanipulations involving addition of NTBF, both
strains of the nontoxigenic strain were used. Formanipulations involving
subtraction of the single ETBF strain or both NTBF strains, the strains
were simply excluded from the pooling step. Final pools weremixed 1:1
with sterile phosphate-buffered saline (PBS) plus glycerol (to achieve a
final concentration of 15%) and aliquots (1 ml) were placed in 2-ml
butyl septum-stoppered amber glass vials (Wheaton) for storage or
gavage into germfree animals.
Gnotobiotic mouse experiments
All mouse experiments were performed using protocols approved by
Washington University Animal Studies Committee. Before the initiation
of experiments, germfree adult male C57BL/6 mice were maintained in
plastic flexible film gnotobiotic isolators under a strict 12-hour light
cycle and fed an autoclaved LF/HPP chow ad libitum (B&K Universal,
diet 7378000). Different treatment groups (that is, mice gavaged with
different microbial communities) weremaintained in separate gnotobi-
otic isolators. All animals studied were included in subsequent analyses.
Male mice were age- and weight- matched before gavage of human
donor microbiota. Investigators were not blinded to either diet or micro-
biota treatments.
Feeding Bangladeshi diet embodiments was initiated 2 days before
colonization with either uncultured fecal microbiota samples or pools
generated from arrayed bacterial culture collections. Diets were extruded
as a paste from their plastic bags into food trays. Fresh 30-g aliquots of
the paste were provided to each singly caged animal per day. For
experiments where diet embodiments were changed, autoclaved Aspen
hardwood laboratory bedding (NEPCO) was replaced at the start of
each embodiment transition to minimize carryover of ingredients from
the preceding diet embodiment exposure.
For the intergenerational transmission experiments, male pups
(n = 3 to 4 for each intact donor microbiota and n = 5 for each culture
collection), representing the combined litter from trio matings were
weaned onto LF/HPP chow and transitioned to the Bangladeshi diet
embodiments at 8 weeks of age (embodiments 1→2→3; 10 days per
diet phase).
Characterizing microbial community composition and
gene expression
Multiplex sequencing of bacterial 16S rRNA PCR amplicons.
Genomic DNA was extracted from mouse fecal pellets using a phenol-
chloroform and beat-beating protocol (45). Bar-coded primers 515F
and 806R were used to generate PCR amplicons covering the V4 region
of bacterial 16S rRNA genes present in the samples. Multiplex sequenc-
ing of pooled amplicons with sample-specific bar codes was performed
using an Illumina MiSeq instrument (250-bp paired-end reads). Reads
were trimmed in silico to 200 bases to retain the highest-quality base
calls, assembled with FLASH (v1.2.11) and demultiplexed in QIIME
(v1.8.0) (21). The 16S rRNA sequence data sets were first analyzed using
open-reference OTU picking (97% ID OTUs) (uclust-ref against the
Greengenes reference database). Sequences (98.7% of the 26,419,497)
that passed QIIME’s default quality filters were successfully clustered
with a reference sequence of≥97% identity. For all subsequent analyses,
OTU tables were rarefied to 4000 reads per sample and filtered to retain
only those OTUs whose relative abundances in fecal microbiota were
≥0.1% in ≥1% of all samples sequenced. Taxonomies were assigned
using RDP classifier 2.4 trained on the manually curated Greengenes
database “Isolated named strains 16S.”
COPRO-Seq of fecal samples collected from mice colonized
with unmanipulated and manipulated culture collections.
Unidirectional reads (75 nt) were generated from fecal DNA samples
using an Illumina MiSeq instrument and trimmed to 50 nt to preserve
the highest-quality reads before mapping onto the genomes of culture
communitymembers. The analytic pipeline for COPRO-Seq is described
in (21) and uses software available at https://github.com/nmcnulty/
COPRO-Seq.
Microbial RNA-seq.
Procedures for performing microbial RNA-seq are detailed in previous
publications (21). Aliquots of cecal contents (~50 mg) that had been
collected at killing (14 dpg) and stored at −80°C were suspended in
500 ml of extraction buffer (200 mM NaCl and 20 mM EDTA), 210 ml
of 20% SDS, 500 ml of phenol/chloroform/isoamyl alcohol (pH 4.5,
125:24:1; Ambion/Life Technologies), and 150 ml of acid-washed glass
beads (212- to 300-mm diameter; Sigma-Aldrich). Cells were lysed by
mechanical disruption using a bead beater (maximum setting, 5 min at
room temperature; BioSpec Products), followed by phenol/chloroform/
isoamyl alcohol extraction and isopropanol precipitation on ice. After
treatmentwith ribonuclease (RNase)–free TURBO-DNase (Ambion/Life
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Technologies), MEGAlear columns (Life Technologies) were used to
remove 5S rRNA and transfer RNAs. A second deoxyribonuclease
(DNase) treatment (Baseline-Zero DNase, Epicentre/Illumina) was
performed before a second MEGAclear purification followed by rRNA
depletion (Ribo-Zero rRNA removal kits, Epicentre/Illumina). cDNA
was synthesized (SuperScript II, Invitrogen), and second-strand syn-
thesis was performedwithRNaseH,E. coliDNApolymerase, andE. coli
DNA ligase (all from New England Biolabs). cDNA libraries were
prepared by shearing samples using a Bioruptor Pico sonicator (Diag-
enode), then size-selecting 150- to 200-bp fragments for blunting, A-
tailing, and ligating sample-specific barcoded sequencing adapters, and
finally PCR enrichment. cDNA libraries were pooled for multiplex
sequencing using an Illumina NextSeq instrument (13.4 ± 1.1 million
unidirectional 75-nt reads/cecal RNA sample), with the exception of the
sample IDs ETBF.expt.112-116 (table S3D), which were sequenced on
the MiSeq platform (6.6 ± 0.7 million unidirectional 75-nt reads per
sample). Identification of differentially expressed genes was performed
in R (version 3.2.3) using the Robinson and Smyth exact negative bino-
mial test with Bonferroni correction (edgeR package, version 3.10.2) as
described previously (21).
Mass spectrometry
Tissues previously stored at −80°C were weighed while frozen and
immediately homogenized in a solution of 50% aqueous acetonitrile/
0.3% formic acid (50mg of tissue permilliliter solution; procedure done
at 4°C using an IKA T25 Ultra-Turrax High-Speed Homogenizer at
maximum setting for 30 to 45 s). Amino acids, acylcarnitines, organic
acids, acyl-CoAs, and ceramides were analyzed using stable isotope
dilution techniques. Amino acid and acylcarnitine measurements were
made by flow injection tandemMS using sample preparation methods
described previously (47, 48). Data were acquired using aWaters Acquity
UPLC system (Waters) equipped with a TQ (triple quadrupole) detector
and a data system controlled by the MassLynx 4.1 operating system
(Waters). Organic acids were quantified (49) using a Trace Ultra Gas
Chromatograph coupled to ISQ MS operating under Xcalibur 2.2
(Thermo Fisher Scientific). Acyl-CoAs were extracted and purified as
described previously (50), and analyzed by flow injection analysis using
positive electrospray ionization on a Xevo TQ-S, TQmass spectrometer
(Waters). Heptadecanoyl CoA was used as an internal standard. Cera-
mides were extracted (51) and analyzed by flow injection tandem MS
using a Xevo TQS spectrometer (Waters).
Histologic analysis
Intestines were harvested and placed in 10% neutral-buffered formalin
for 3 hours at room temperature, washed in 70% ethanol, prepared as
“Swiss rolls,” paraffin-embedded, and 5-mm-thick sections were cut.
Hematoxylin and eosin–stained sections were evaluated for alterations
in crypt number (evaluated by crypt density), crypt depth, villus height,
epithelial proliferation [measured by M-phase cells per crypt (n =
100 crypts per specimen evaluated) and neutrophils per crypt unit (n =
100 crypt units evaluated per specimen)]. All slides were blinded before
quantification.
Immune cell isolation and characterization
Cells from the spleen, mesenteric lymph node, and lamina propria of the
colon were isolated as described previously (52), with two minor mod-
ifications: (i) Hanks’ Balanced Salt Solution (HBSS) was used in place of
Dulbecco’s PBS, and (ii) collagenase type VIII (Sigma-Aldrich) was used
at a concentrationof 0.1mg/ml for isolationof colonic lamina propria cells.
Intracellular cytokine staining was performed on cell suspensions
frommesenteric lymph nodes and colonic lamina propria after restimu-
lation in round-bottom 96-well plates in complete RPMI containing
b-mercaptoethanol (0.05 mM; Sigma-Aldrich) supplemented with
phorbol 12-myristate 13-acetate (50 ng/ml; Sigma-Aldrich), ionomycin
(750 ng/ml; Sigma-Aldrich), and brefeldin A (eBioscience; diluted
according to the manufacturer’s recommendations). Cells were restimu-
lated at 37°C for 3 hours in a humidified CO2 tissue culture incubator.
Cells in which FoxP3 was assessed were not restimulated.
Cell surface and intracellular staining was performed as described
previously (52) with the following two modifications: (i) cells were
washed free of excess protein from restimulation medium, or from the
HBSS/0.1% bovine serum albumin (BSA) (w/v) buffer, using HBSS
without BSA, and (ii) the incubation containing anti-CD16/CD32
[Fc block (2.4G2); BD Pharmingen] also included Live/Dead Fixable
Aqua Dead Cell Stain (Life Technologies) to allow identification and
removal of dead cells during the analysis that followed fixation and
permeabilization. Cells were stained with the following antibodies:
CD4 eFluor 450 (GK1.5, eBioscience), CD4 allophycocyanin (RM4-5,
BD Pharmingen), T cell receptor b (TCR-b) Alexa Fluor 488 (H57-597,
BioLegend), CD8a allophycocyanin (53-6.7, BioLegend), FoxP3 eFluor
450 (FJK-16s, eBioscience), and IL-17A phycoerythrin (TC11-18H10.1,
BioLegend). Appropriate isotype control antibodies were purchased
from the same vendors that supplied antibodies targeting molecules
of interest. Cells were analyzed with an Aria III flow cytometer (BD
Biosciences), and data were analyzed with FlowJo software (Tree Star;
version 7.6.1).
Measurements of serum cytokine levels
Blood was collected via retro-orbital phlebotomy at the time of killing,
and derived serum samples were analyzed, alongside standards, using
the Bio-Plex Pro Mouse Cytokine 23-plex Assay (Bio-Rad) following
the manufacturer’s instructions. Technical duplicates were performed
for each sample.
Statistical analyses
Routine statistical analyses were performed in R (version 3.1.2). P < 0.05
was considered to be statistically significant. Specific statistical tests are
noted in the figure legends and throughout the text. Bonferroni correc-
tion formultiple hypotheses was applied to identify genes that exhibited
significant differences in their expression between treatment groups.
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Nature Reviews Microbiology 10, 607-617 (September 2012)
From Alfred Hershey and Martha Chase’s studies indi-
cating that DNA is the genetic material1, to Francis Crick 
and Sydney Brenner’s experiment establishing the triplet 
nature of the genetic code2, viruses that infect bacteria 
(referred to below as phages) have helped define the fun-
damental components of modern biology. Most of the 
tools for early molecular biology arose from the work 
of phage biologists3. The first genomes sequenced were 
from phages and other viruses, and the first compari-
sons of multiple genomes were carried out on phages 
of Lactobacillus and Mycobacterium spp. These early 
studies showed that there is extensive diversity in essen-
tially every phage community. It is now clear that viruses 
are the most diverse and uncharacterized components 
of the major ecosystems on Earth4 and have intricate 
roles in ecosystem function that go far beyond simple 
predator–prey dynamics5 (BOX 1).
The clinical world has become increasingly inter-
ested in phage-based therapeutics because of the 
increased prevalence of antibiotic-resistant bacte-
ria6. The idea of using phages as therapeutic tools is 
not new. Félix d’Herelle, the co-discoverer of phages, 
recog nized their potential medical applications nearly 
a century ago7, and his first phage therapies were 
tested as early as 1919 (REF. 8). However, our then-
rudimentary understanding of the composition and 
dynamic operations of the human microbiome, our 
lack of knowledge of phage biology, and poor quality 
control during phage production made this therapeutic 
approach unreliable9.
In this Review, we detail recent advances in the rising 
field of viral metagenomics, with an emphasis on our 
current views of the phage communities associated with 
the human gut. We do not discuss many of the mecha-
nisms of resistance to phages, such as CRISPRs (clustered 
regularly interspaced short palindromic repeats), or the 
extremely large field of eukaryotic virus discovery, which 
is being propelled by metagenomics, as these topics have 
been reviewed elsewhere10–14. Instead, we focus exclu-
sively on viruses that infect bacteria. There are many 
challenges facing phage metagenomics at the present 
time, several of which are discussed below; some of the 
technical improvements that are required to overcome 
these challenges are outlined in BOX 2.
Methods for viral metagenomics
The introduction of small subunit (SSU) rRNA — that 
is, 16S rRNA — as a reliable bacterial and archaeal 
phylo genetic marker15–17 allowed remarkable insights to 
be gained about the diversity and dynamics of micro-
bial communities. Phylogenetic-marker ‘envy’ rapidly 
‘infected’ the psyche of phage biologists: they did not 
have an SSU rRNA equivalent, and there was (and still is) 
no conserved protein or gene enabling a similar charac-
terization of all or even the majority of phages present in 
a sample. Efforts to characterize phage diversity focused 
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CRISPRs
(Clustered regularly 
interspaced short palindromic 
repeats). Widespread genetic 
systems in bacteria and 
archaea, consisting of multiple 
copies of palindromic repeats 
flanking short spacers of viral 
or plasmid origin. CRISPR 
elements provide acquired 
resistance to foreign DNA.
Going viral: next-generation 
sequencing applied to phage 
populations in the human gut
Alejandro Reyes1, Nicholas P. Semenkovich1, Katrine Whiteson2, Forest Rohwer2  
and Jeffrey I. Gordon1
Abstract | Over the past decade, researchers have begun to characterize viral diversity using 
metagenomic methods. These studies have shown that viruses, the majority of which infect 
bacteria, are probably the most genetically diverse components of the biosphere. Here, we 
briefly review the incipient rise of a phage biology renaissance, which has been catalysed by 
advances in next-generation sequencing. We explore how work characterizing phage 
diversity and lifestyles in the human gut is changing our view of ourselves as supra-organisms. 
Finally, we discuss how a renewed appreciation of phage dynamics may yield new 
applications for phage therapies designed to manipulate the structure and functions of  
our gut microbiomes.
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Virus-like particles
(VLPs). Particles that can be 
recovered from microbial 
communities using physical 
separation methods such as 
density gradient ultracentrifu-
gation and/or filtration. Purified 
VLPs have physical 
characteristics that resemble 
those of viruses, although their 
capacity for infection has to be 
subsequently defined.
Virotype
A taxonomic classification that 
is typically based on a selected 
percentage identity threshold 
among viral reads, rather than 
on phylogenetic markers.
Multiple displacement 
amplification
A method for exponential 
isothermal amplification of a 
DNA template using  
φ29 DNA polymerase and 
random primers. Exponential 
amplification is achieved by 
attachment of the polymerase 
to newly elongated fragments, 
coupled with the strong 
displacement activity of the 
enzyme on extension.
Deep biosphere
The deepest oceanic regions in 
which life is supported.
on partially conserved fragments of phage genes such as 
those encoding polymerases. However, this method was 
useful only within certain viral families18–20. Horizontal 
gene transfer further complicates the use of marker genes 
in phages. For example, most members of the order 
Caudovirales have identifiable conserved genes, includ-
ing those encoding terminases, portal proteins and 
capsid proteins, but horizontal transfer and recombina-
tion events generate extensive genome mosaicism that 
challenges phylogenetic characterization21. The arrival 
of next-generation sequencing, together with methods 
for purifying virus-like particles (VLPs), set the stage for 
defining viral diversity using shotgun sequencing.
Purification of VLPs. Although viruses outnumber 
microbial cells 10:1 in most environments, viral DNA 
represents 2–5% of the total DNA in a microbial com-
munity22–24. For this reason, it is often desirable to 
separate viruses from microbial cells. If the sample 
volume is large and the viral density low (such as in 
ocean environments), tangential flow filtration can 
be used to recover and concentrate VLPs. For solid 
samples with a high viral density, such as faeces, a 
common approach is to resuspend the material in an 
osmotically neutral buffer, followed by one or more 
steps designed to remove large particles, including 
undigested or partially digested food fragments and 
microbial cells, by caesium chloride density gradi-
ent ultracentrifugation25 and subsequent filtration 
(FIG. 1). This procedure has been successfully applied to 
faecal material that has been stored at −80 °C for sev-
eral years, without any pre-processing of the sample, 
indicating that VLP structures are stable under conditions 
of freezing and thawing22.
Amplification of VLP-derived DNA. After VLPs are puri-
fied, non-encapsulated free nucleic acids are removed 
by treatment with DNase and RNase, and VLP-derived 
nucleic acids are then isolated. The methods chosen 
determine the purity of the DNA and RNA, influence the 
DNA and RNA yields, and represent a selection step that 
can bias the subsequent interpretation of virotype abun-
dance and viral community diversity26. Unfortunately, the 
yield of DNA following extraction of nucleic acids from 
purified VLPs is often below the required minimum for 
sequencing. Therefore, a range of amplification methods 
have been developed, such as random amplified shotgun 
library (RASL)27 and linker-amplified shotgun library 
(LASL)28, among others29–32. Caveats concerning random 
PCR amplification of viral DNA include an uneven cov-
erage of viral genomes, the limitation of this approach to 
double-stranded DNA (dsDNA) templates, and an inher-
ent bias attributable to the exponential amplification of 
mixed templates. Another common method uses the 
phage-derived φ29 polymerase for multiple displacement 
amplification (MDA)33. MDA takes advantage of the high 
processivity of this DNA polymerase (>70,000 nucleotides 
(nt) per association–dissociation cycle) and its strong 
strand displacement capability, which together permit the 
amplification of complete viral genomes. The result is a 
fast method that can efficiently amplify minute amounts 
of both single-stranded DNA (ssDNA) and dsDNA. 
Although the method is fast, it is not without flaws, 
including the overamplification of small circular ssDNA 
Box 1 | Phage–bacterial host dynamics: lessons learned from environmental ecosystems
Most of life on Earth exists as bacteria and archaea in oceans, sediments, land and the deep biosphere112. In the early 
1980s, researchers became aware that there are literally millions of actively growing microorganisms per millilitre of sea 
water, and efforts to characterize the impact of phage life cycles on planetary-scale biogeochemistry were initiated113–116. 
As an example of how dramatic the effects of phages can be, consider the widespread cyanobacterial clades 
Prochlorococcus and Synechococcus. The species in these two genera of unicellular algae carry out about half of the 
primary production in the world’s oceans; these bacteria are also infected with cyanophages, and variations in cyanophage 
and bacterial concentrations are tied to daily and seasonal cycles115. The isolation and characterization of phages infecting 
Synechococcus?????????????????????????Prochlorococus?????????????????????????????? ??? ?????????????????????????
widespread, often infecting 40–50% of cyanobacteria, but also that they kill 10–50% of their hosts daily114,115, rapidly 
driving the diversification of their hosts as these bacteria co-evolve resistance117, and simultaneously driving carbon into 
a dissolved form when bacterial cells lyse. When levels of available resources are low, cyanophages can enter a lysogenic 
state. A growing list of genes that are important for bacterial host metabolism and function have been found in marine 
phages, including photosystem genes that can increase the host’s photosynthetic output and maintain energy 
production during infection so that phages can eventually lyse their host cells51,118–120. Lysogeny may be an important 
lifestyle under a number of suboptimal conditions, including when host abundance or nutrient abundance is low121.
Bacteria can use temperate phages to enable invasion of new habitats. When part of the bacterial population is 
sacrificed through phage lysis, the released phages will target competitors but allow bacterial kin harbouring the 
prophages to survive, as they are resistant to attack owing to a process called superinfection exclusion122–125.
The concept that a virus can have a beneficial effect beyond that experienced directly by its host cell is not novel. 
Three-way symbioses have been well described in macro- and micro-ecosystems. For example, a symbiotic bacterium 
that inhabits the pea aphid protects the aphid from a wasp that can otherwise lay eggs in the aphid haemocoel; this 
protection is conferred by a phage-encoded toxin expressed by the bacterium126,127. Drought, heat and cold tolerance are 
conferred to plants through viruses122,128. In Yellowstone National Park, USA, a fungal endophyte infecting panic grass 
confers thermal tolerance, allowing the grass to grow in hot geothermal soils; however, the fungus is not heat tolerant 
without the virus that infects it129. In a phage-related example, there is a reported case of phage-associated corynetoxin 
synthesis in the bacterium Rathayibacter toxicus???????????Clavibacter toxicus??? ???????????????????????? ?????????????????
makes the grass toxic to grazing animals such as sheep130.
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Prophages
Temperate phages in a 
host-incorporated state.
α-diversity 
Diversity, whether defined 
using taxonomic or functional 
characteristics, within a 
particular locale (habitat) at a 
particular moment in time.
β-diversity
Diversity measured between 
samples or locales at a 
particular moment in time or 
over time.
γ-diversity
A combination of alpha and 
beta diversity.
viruses34 and the potential formation of chimaeras35,36. 
Procedures for avoiding some of these limitations con-
tinue to be developed37,38, including a novel transposon-
based method for rapidly generating DNA libraries 
from small quantities of dsDNA39. RNA viruses can be 
sequenced by reverse transcription followed by appli-
cation of the protocols described above. Alternatively, 
whole-transcriptome amplification approaches can 
be used40.
Sequencing strategies. Although sequencing costs are 
falling at an astonishingly rapid rate as newer technolo-
gies offer higher degrees of parallelism (that is, greater 
numbers of reads per run, and multiplex sequencing 
using sample-specific DNA bar-codes), read length 
matters41. When characterizing a viral community from 
which most of the sequences are novel and enriched in 
regions of low-complexity repeats, obtaining the longest 
possible reads will aid accurate assembly and taxonomic 
assignment41,42. The earliest next-generation sequenc-
ing analyses were powered by the 454 GS20 instru-
ment (from Roche) with ~100 nt reads. Advances in 
pyrosequencing technology, including today’s 454 FLX+ 
machine, have produced average read lengths that exceed 
800 nt22,23,43–46. Most recently, total microbial-community 
DNAs have been subjected to deep shotgun sequencing 
with more highly parallel Illumina instruments; analyses 
of the resulting metagenomic data sets have shown that 
the percentage of reads with similarity to known viral 
sequences is generally less than 0.01%30,47,48. This low 
value is in part due to the short read length (≤100 nt). 
However, the percentage of similarity increases when 
VLPs are purified32. Other studies have obtained better 
assignments by assembling the short reads49,50.
In summary, researchers engaged in viral metagen-
omic studies have tended to opt for technologies that 
prioritize long read lengths over those that offer short 
read lengths but higher throughput. However, as the 
high-throughput platforms approach 150 nt read lengths 
and 250 million reads per lane (such as the Illumina 
HiSeq 1500 and 2500 instruments), and as the cost per 
read falls, we will undoubtedly see a rapid transition to 
these types of sequencers — so long as improvements in 
assembly algorithms keep pace (FIG. 1).
Computational approaches for characterizing sequenced 
viromes. To address the question of viral community 
composition, shotgun metagenomic sequences are typi-
cally compared to individual viral genomes. Although 
public sequence databases have expanded considerably 
— from 500 viral genomes in 2007 to more than 3,000 
full viral genomes in 2012 — the number of deposited 
genomes is far less than the expected number of viro-
types present in 100 litres of sea water51. Compounding 
this problem, existing databases include few viral pro-
teins in their training sets, meaning that many taxo-
nomic assignments are based on proteins that have 
been transferred from a virus to a microbial host or 
that are present in prophages and are described as part 
of a microbial genome. Databases with a particular 
focus on viruses are under development and include A 
Classification of Mobile Genetic Elements (ACLAME)52 
and Phage SEED53. Novel data analysis pipelines are also 
being constructed to improve the accuracy and effi-
ciency of homology searches (see REFS 54–59, and Phage 
SEED and Virome).
When taxonomic and functional assignments have 
been made for a given sample, a viral community profile 
can be created that characterizes the diversity present in 
that sample. Multidimensional reduction methods such 
as principal component analysis (PCA) and hierarchical 
clustering have been used to visualize similarities among 
viral communities, and methods such as supervised 
learning can help to identify discriminatory features.
Given that most of the available viral metagenomic 
data lack similarity to entries in databases, similarity-
independent methods have been developed to better 
understand viral community structure. One example, 
Box 2 | Technical challenges in viral metagenomics
?????????? ????????????????????????????? ????????????? ??????????????????????????????????? ??????????? ???????????????????
biomass, and methods for less biased amplification of extracted nucleic acids before shotgun sequencing.
??Improved methods for deep-draft assemblies of full-length viral genomes. Particularly problematic are the ends of 
phage genomes, which can be blocked or permuted or can have hairpins.
????????????????? ?? ????????????????????? ????????????????????? ??????????????? ???????????????????? ??????
α-diversity, β-diversity and γ-diversity, in order to describe the pan-virome in a given environment.
??New and better tools for defining the host specificity of known and novel phages from either assembled genomes or 
?????????????????????????????????????????????????????????? ???????????? ?? ????????? ???????????????
??Improved methods of experimentally and computationally assigning functions to ‘conserved’ viral genes with no known 
?????????????????????????? ??????????????? ???? ??????????????????????????? ???????????? ???????????? ??????
??Better ???????? and ??????? models for determining phage–bacterial host dynamics and the impact of these interactions 
on energy availability and niche partitioning in a microbiota.
??Experimental and computational methods, and related visualization tools, for efficient analyses of temporal variation in 
model microbial communities, and for measuring the effects of perturbations.
??Models for predicting the cost or benefit of having prophage present in a candidate probiotic species; for example, 
weighing invasiveness and persistence in a targeted microbiota.
??Methods to test the utility of phages to directly perturb a targeted microbiota in ways that facilitate invasion by a 
probiotic species or species consortium.
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Frozen faecal sample
V?? puri?cation
and concentration
??A extraction
and ampli?cation
??A sequencing
?multiplexing with 
sample-speci?c 
bar-codes?
? ?assage through ?.?? ?m 
and ?.22 ?m diameter ?lters
? ?ensity gradient 
ultracentrifugation
? ?recipitation with
polyethylene glycol
? ?uclease treatment
? ?ultiple displacement 
ampli?cation ? ?A?
? ?inker ampli?ed shotgun 
library ??AS??
? Random ampli?ed shotgun 
library ?RAS??
? ??? pyrosequencing
?F?? Titanium or F????
? Illumina sequencing 
?HiSeq or ?iSeq?
?lassi?cation 
of reads by 
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Pan-genome
The global gene repertoire of  
a microbial species; defined by 
sequencing the genomes of 
isolates of that species 
obtained from a single or 
multiple habitats.
Bacterial phylotypes
Taxonomic classifications that 
are based on phylogenetic 
markers, classically the 16S 
rRNA gene. Isolates can be 
arbitrarily assigned to a 
species-level phylotype if they 
share ≥97% sequence identity 
among their 16S rRNA genes.
PHACCS (Phage Communities from Contig Spectrum), 
was designed to quantify virotypes60,61 on the basis of the 
assumption that if a virotype is present in high abun-
dance in a VLP sample, it is more likely to be assem-
bled into a large contig. Moreover, we can posit that if 
assembly of a single sample data set allows prediction 
of community structure and diversity, then pooling two 
samples together and carrying out a cross-assembly 
analysis could determine the inter-sample diversity 
(by, for example, using MaxiPhi62). Another alternative 
for identifying shared viruses among different sam-
ples comes from crAss, an algorithm that allows for 
the simultaneous cross-assembly of all the samples in 
a data set as opposed to the pairwise assemblies used in 
MaxiPhi. As more tools are developed, special attention 
should be given to the assembly parameters in order to 
prevent mixed assemblies and chimaeras between viral 
genomes (FIG. 1).
Phages in the human gut
The gut provides an exciting place to characterize the 
role of phages in community assembly and dynamics. 
Assembly of the human gut microbiota begins at birth, 
with evolution towards an adult-like configuration dur-
ing the first 3 years of life63. The importance of early envi-
ronmental exposures is emphasized by the fact that the 
overall phylogenetic composition of the gut microbiota 
is not significantly more similar in adult mono zygotic 
twins than in dizygotic twins, and the fact that family 
members have a higher degree of similarity in the gut 
microbiota than unrelated individuals living in different 
households. These patterns are robust to different cul-
tural traditions, and the observations about mono- versus 
dizygotic twins apply to children as well as teenagers and 
adults63,64. Microorganisms in this densely populated eco-
system are engaged in a constant fight for nutrients and 
survival. Peristalsis moves an ephemeral menu of dietary 
components along the cephalocaudal axis of the intes-
tine, and the microbial inhabitants face the omnipresent 
threat of washout from the gut ‘bioreactor’. Maintaining 
a foothold in this ecosystem depends not only on physi-
cal interactions with the perpetually renewing mucous 
layer and partially digested food particles, but also on 
functional interactions with other community members. 
Preserving functional redundancy contributes to com-
munity resilience, and horizontal gene transfer provides 
an opportunity to constantly modify the pan-genome of a 
given species-level bacterial phylotype. Each adult appears 
to harbour a persistent collection of one hundred, or at 
most a few hundred, species in their intestines, although 
strain level diversity is great24,65,66. Although the propor-
tional representation of taxa changes as the community 
responds to various environmental perturbations, intra-
personal variation in species content is considerably less 
than interpersonal differences63,64,67,68.
As our knowledge of inter- and intrapersonal varia-
tions in the microbiota has increased, a lagging question 
has been the role of phages in shaping the properties 
of these microbial communities. Although a number 
of individual phages have been extensively character-
ized, providing an important genomic context against 
which metagenomic data can be interpreted, recently 
more attention has been given to phage dynamics at 
the microbial community level. In 2003, the first report 
of a human-associated gut virome was published; it 
described the results of shotgun Sanger sequencing of 
DNA from VLPs isolated from a faecal sample obtained 
from a single healthy adult. The identifiable fraction of 
the virome was dominated by phages, including tem-
perate phages. This report estimated that there were 
1,200 different virotypes in the single sample analysed, 
with the majority assigned to the Siphoviridae family28. 
Siphoviridae and temperate phages have subsequently 
been reported to be the most abundant identifiable 
viruses in other sampled faecal viromes, followed by 
members of the family Podoviridae22,23,69.
Figure 1 | Experimental and computational methods for the characterization of 
the phage populations present in the human gut microbiota. See main text for 
further details. VLP, virus-like particle.
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Lysogenic
Pertaining to a temperate 
phage: a state in which linear 
(1:1) replication is achieved 
through integration of the 
phage genome into the 
chromosome of the bacterial 
host (or, more rarely, the phage 
exists as a plasmid within the 
host cell). The integrated 
phage transcribes genes that 
repress lytic action, and in 
some cases expresses genes 
that promote the fitness of the 
bacterial host.
Kill-the-winner virus–
bacterial host dynamic
A model for the population 
dynamics of phage–bacterium 
interactions; this model 
postulates that an increase in a 
host population (the winner) is 
followed by an increase in its 
corresponding phage predator, 
resulting in an increase in the 
rate at which the winner is 
killed.
The prominence of members of the family 
Microviridae in adult human gut microbiota was ini-
tially dismissed as an artefact of the MDA method, 
which has a preference for ssDNA. However, a novel 
branch of the family Microviridae has been identi-
fied recently, from prophages present in the genomes 
of Bacteroides and Prevotella spp.70. These two gen-
era are prominently represented in the microbiota of 
adult human populations living in a number of diverse 
geographical areas63,71. Another study characterizing 
Microviridae members from healthy human donors 
also clustered these novel viruses with prophages from 
Bacteroides and Prevotella spp.69. These analyses sug-
gest that Microviridae is an important viral family 
in the human gut, and also that what was previously 
considered to be an exclusively lytic phage can in fact 
integrate into bacterial hosts in an environment that 
encourages a temperate (lysogenic) virus–host lifestyle 
(see FIG. 2 and below).
Marine environments can contain millions of differ-
ent virotypes in a single sample51. By comparison, none 
of the human faecal samples characterized thus far has 
had more than 1,500 virotypes. Moreover, the ratio of 
virotypes to species-level bacterial phylotypes is 10:1 
in the ocean but closer to 1:1 in the gut22. Microscopy 
counts have further validated these estimated ratios, 
demonstrating an average of 108–109 VLPs per gram of 
faeces compared with ~109 bacterial cells per gram69. 
These findings also support the notion that phages 
exhibit a more temperate lifestyle in the gut, in contrast 
to the active kill-the-winner virus–bacterial host dynamic 
manifest in marine environments.
The temperate lifestyle of phages observed in the 
gut, along with bacterial CRISPR elements involved in 
conferring immunity to infection with foreign DNA 
(including phages), has facilitated bioinformatic efforts 
to discover new phages in this body habitat. Recently, 
data sets obtained from deep shotgun sequencing of 
human faecal-community DNA24 were used to extract 
CRISPR spacers present in gut bacterial genomes72. 
These spacers were then used to query data sets of shot-
gun sequencing reads from faecal VLP-derived DNA22,23, 
and contigs assembled from total faecal-community 
DNA24. This approach allowed a large collection of these 
previously unassigned contigs to be designated as viral 
and assigned to potential bacterial hosts. This study also 
led to an appreciation of the wide distribution of novel 
phages across human gut communities.
Figure 2 | Potential consequences of a temperate phage life cycle in the human gut. Metagenomic studies of viruses 
suggest that a temperate lifestyle is dominant in the distal human gut, in contrast to the the lytic lifestyle observed in open 
oceans. This temperate lifestyle can have benefits for the phage and the bacterial host, and can alter phage–host dynamics. 
Integration as a prophage (part a) protects the host from superinfection, effectively ‘immunizing’ the bacterial host against 
infection from the same or a closely related phage. Furthermore, the genes encoded by the phage genome may expand the 
niche of the bacterial host by enabling metabolism of new nutrient sources (for example, carbohydrates), providing 
antibiotic resistance, conveying virulence factors or altering host gene expression. This temperate (lysogenic) life cycle 
allows phage expansion in a 1:1 ratio with the bacterial host. If the prophage conveys increased fitness to its bacterial host, 
there will be an increased prevalence of the host and phage in the microbiota. Induction of a lytic cycle (part b) can follow a 
lysogenic state and can be triggered by environmental stress. As a consequence, bacterial turnover is accelerated and 
energy utilization is optimized through a ‘phage shunt’, in which the debris remaining after lysis is used as a nutrient source 
by the surviving bacterial population. Furthermore, a bacterial subpopulation that undergoes lytic induction sweeps away 
other sensitive species and increases the niche for survivors (that is, bacteria that already have the specific phage integrated 
into their genome). Periodic induction of prophages can also lead to a constant-diversity dynamic139, which helps maintain 
community structure and functional efficiency. Novel infections or infections of novel bacterial hosts by phages (part c) 
bring the benefit of horizontally transferred genes and create selective pressure on the hosts for diversification of their 
phage receptors, which are often involved in carbohydrate utilization. HGT, horizontal gene transfer.
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Temporal variation. To date, only three reported 
metagenomic studies of the human gut virome have 
characterized temporal variation22,23,73. One of these 
studies used VLPs that were isolated from frozen faecal 
samples collected from four adult female monozygotic 
twin pairs and their mothers at three time points over a 
12-month period22. VLP-derived virome data sets were 
compared to data sets of both sequenced bacterial 16S 
rRNA genes, and shotgun reads from total faecal-com-
munity DNA generated from the same faecal samples 
used to prepare the VLPs. The results disclosed that the 
viromes of co-twins and their mothers exhibited a sig-
nificantly greater degree of interpersonal variation than 
did the corresponding bacterial communities. Despite 
the marked interpersonal variation in gut viromes and 
their encoded gene functions, intrapersonal diversity 
was extremely low: >95% of virotypes were retained 
over the period surveyed, and DNA viromes were 
dominated by a few temperate phages that exhibited 
remarkable genetic stability (>99% sequence conserva-
tion). These observations suggest that a temperate viral 
lifestyle is more prevalent in the distal intestine than a 
kill-the-winner dynamic (see FIG. 2).
Another study of temporal variation involved adults 
who were subjected to a defined diet for a period of 
8 days23. During this time, both bacterial and viral fae-
cal communities changed in a comparable manner. 
Importantly, interpersonal variation at the late time 
points was reduced among individuals consuming the 
same diet, suggesting that diet has an important effect 
in shaping both bacterial and viral components of the 
microbiota.
A third study examining temporal variation charac-
terized the DNA virome of a 1-week-old healthy infant 
and used DNA microarrays to compare relative viral 
abundances in the faecal microbiota between postnatal 
week one and two73. The results showed that the viral 
population changes drastically in the early stages of 
human life: more than half of the virotypes that were 
present at week one were undetectable by week two. 
Although these findings contrast with the stability of the 
DNA viromes in healthy adult faeces, they are consistent 
with the dynamic and rapid nature of assembly of the 
infant bacterial microbiota63,74.
Functions encoded in phage genomes. There are a num-
ber of examples of known phage-encoded host fitness 
factors in gut bacteria (for example, the phage λ lipo-
protein Bor and outer-membrane protein Lom, and 
the phage 933W Shiga-like toxin 2 (SLT2; also known 
as Stx2 (REFS 75,76)), but most of these appear to be 
virulence determinants of one kind or another. When 
comparing purified VLP-derived viromes and faecal 
microbiomes in the study of monozygotic twins, phages 
have been shown to exhibited enrichment for genes 
involved in anaerobic nucleotide synthesis, as well as 
cell wall biosynthesis and degradation22. Other distinc-
tive features of phage genomes include genes that can 
alter bacterial phage-receptors and prevent superin-
fection77. Interestingly, many phage receptors may be 
involved in carbohydrate transport and utilization. In an 
environment such as the gut, where carbohydrate utiliza-
tion is an important fitness factor, mobilization of these 
bacterial genes by phages could endow bacterial hosts 
with benefits (FIG. 2). There are probably a great number 
of bona fide metabolic and other fitness factors that have 
yet to be characterized which are encoded by phages.
Intriguingly, new evidence suggests that carbohy-
drate-binding components of the human gut virome can 
change at an extremely high rate. A recent metagenomic 
study examining VLPs purified from faecal samples 
collected from 12 humans identified 51 hypervariable 
loci — areas with mutation rates that are much higher 
than those for the rest of the viral genomes50. Structural 
predictions for proteins putatively encoded by these 
regions revealed little homology to known folds; how-
ever, some of these proteins have similarity to immu-
noglobulin superfamily domains, and others to C-type 
lectin domains that participate in carbohydrate binding. 
Moreover, these loci appear to be specifically targeted 
for mutation by a reverse transcriptase-based mecha-
nism, suggesting that a crucial functional advantage is 
provided by these hypervariable loci. It is tempting to 
speculate that these loci confer a selective advantage 
to phages, enabling immune evasion through immu-
noglobulin A (IgA) binding, or improving the chances 
of infecting a host cell in the rapidly changing condi-
tions of the gut through adaptable binding to relevant 
environmental materials or bacterial surface receptors. 
There is a well-documented precedent for this sce-
nario: hypervariable loci confer a fitness advantage in 
phages that infect Bordetella spp., as they allow tropism 
switching in the phage receptor-binding protein78. The 
hypothesis that these loci allow a phage to bind IgA or 
environmental ligands is speculative and needs experi-
mental validation; non-receptor structural phage pro-
teins have been found to contain Ig-like domains, which 
may aid in host binding by weakly interacting with the 
cell surface79.
RNA virome. The RNA virome of two healthy adults has 
been characterized by purifying and sequencing the RNA 
from VLPs80. In this study, most RNA viruses appeared 
to be consumed together with food. Indeed, a pepper-
associated virus (pepper mild mottle virus) constituted 
more than 80% of the identifiable gut viruses. The only 
animal-infecting RNA virus observed was a picobirna-
virus that had previously been found in the faeces of 
healthy individuals as well as in the faeces of patients 
with diarrhoea; this virus has not been associated with 
any particular disease to date.
Comparative studies of other mammals
Comparative studies of different mammalian species 
represent a source of information about the effects of 
environmental factors, including diet81,82, and various 
host factors on phage diversity in the gastrointestinal 
tract. Extensive surveys have been conducted of viruses 
associated with different mammalian species, with the 
aim of finding potential sources of zoonoses, uncov-
ering the aetiology of animal diseases and identifying 
common mammalian viruses13. These studies, which 
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Coliphages
Phages that infect coliform 
bacteria, in particular 
Escherichia coli.
include surveys of mammals occupying distinct habi-
tats29,31,32,83–88, identified viruses from certain families 
in the human gut virome, further underscoring the 
prevalence and long-standing nature of the evolved 
virus–mammalian host relationship (BOX 3). In all these 
studies, ssDNA viruses were found to be ubiquitous and 
accompanied in some cases by positive-sense ssRNA 
enteric viruses43,87,88.
An early survey of coliphages in cows, pigs and 
humans89 showed that these phages are present in titres 
of up to 107 VLPs per gram of faeces and that temperate 
coliphages are the most common. Interestingly, humans 
and pigs (omnivores with simple guts) had higher counts 
of temperate coliphages than cows (herbivores with fore-
gut fermentation chambers). In an independent study, 
estimates of phage diversity from bovine rumen fluid90 
suggested that up to 28,000 different virotypes can be pre-
sent in titres as high as 109 VLPs per millilitre of sample, 
hinting at a strikingly higher viral diversity and abun-
dance in the cow gut than in the human gut. In contrast 
to the large interpersonal variation observed in human 
gut viromes22,23, this latter study demonstrated a high 
degree of similarity between the phage communities of 
co-habiting animals on a similar diet. Metagenomic stud-
ies in horses83 (herbivores with a hindgut fermentation 
chamber) revealed an intermediate level of phage diver-
sity between that documented in herbivorous foregut-
fermenting ruminants and omnivorous mammals with 
simple guts.
Together, these studies suggest that diet, gut physi-
ology and potentially the transit time of food all have 
important roles in determining the life cycle and diversity 
of phages in the mammalian gut. Further dissection of 
these relationships requires manipulable, representative 
and defined in vivo models. Moving in this direction, 
Maura and colleagues used mice to study the effects of 
a lytic enteric phage, observing stable long-term phage 
replication over 3 weeks91. As noted below, gnotobiotic 
mouse models might also be very informative.
Phage therapy
Much has already been written about the history, suc-
cesses and failures of phage therapy. Most of the stud-
ies to date have focused on the use of lytic phages to 
destroy pathogenic bacteria92,93 (FIG. 3). Clinically ori-
ented phage research began soon after the discovery of 
phages, when Félix d’Herelle used phages to treat bacil-
lary dysentery in a number of human patients8. However, 
this optimistic start led to several misconceptions and 
missteps, both scientific and political, regarding the use 
of phages. d’Herelle incorrectly assumed that there was 
only one universally efficacious strain of lytic phage94, 
although we now know that phages exhibit exquisite host 
cell specificity. In the 1930s, pharmaceutical companies 
began distributing enormous amounts of lytic phages as 
generic antibacterial therapies, but in part because of the 
perceived universality of phages, they had little knowledge 
of the components of these products.
In retrospect, we know that many of the commonly 
used phage preparations were destroyed by the organo-
mercury preservatives added to the vials that contained 
the preparations, or were contaminated with bacterial 
exotoxins secreted by the cultures used to generate the 
phages95. Inevitably, these problems, along with manu-
facturing inconsistencies (the supposedly standardized 
strains of phages would change from batch to batch), led 
to distrust among the medical and scientific community.
The recent resurgence of phages as possible thera-
peutic agents has been driven by a number of factors. 
The alarming prevalence of antibiotic-resistant strains 
of pathogenic bacteria, combined with the inexorable 
spread of antibiotic-degrading enzymes, such as New 
Delhi metallo-β-lactamase (NDM1), have led to calls for 
new therapeutic strategies96. From a practical standpoint, 
efforts in antibiotic discovery have produced few novel 
compounds over the past decade97. Phages are promising 
tools because they are easy to manufacture, have good 
host specificity and can be genetically manipulated. 
Moreover, resistance to phages may develop more slowly 
than resistance to antibiotics, although the reasons for 
this are multifaceted98. Phage resistance can occur spon-
taneously in cultures (as frequently as 1 in 105 cells), but 
there can be fitness costs associated with resistance. By 
contrast, many forms of antibiotic resistance cannot 
occur spontaneously but instead require the introduc-
tion of a foreign DNA element. In many ways, address-
ing bacterial resistance is much easier with phages than 
with antibiotics because one can isolate different phages, 
or the phage may spontaneously mutate to overcome 
host resistance.
Perhaps a more interesting question, in the context of 
community dynamics and our growing understanding 
of the virome and microbiome, is whether we can pro-
duce more subtle phenotypic shifts in an ecological niche. 
Rather than using phages to destroy a single pathogenic 
Box 3 | Characterizing the eukaryotic virome in the gut of healthy individuals
The eukaryotic virome can be considered from at least three different perspectives: 
viruses associated with the eukaryotic component of the gut microbiota, viruses 
associated with various human cell populations exposed to this microbiota, and viruses 
associated with ingested food. Metagenomic studies of faecal microbial communities 
from healthy individuals indicate that these communities are dominated by phages 
rather than eukaryotic DNA viruses22,23,28,50,69,73. Eukaryotic RNA viruses are abundant but 
appear to be largely derived from food80.
Our view of the eukaryotic virome in the gut comes largely from metagenomic studies 
of patients with various gastrointestinal diseases131–137. These studies have identified 
???????????????????????????????????????????????????????????????????? ?????????????????
novel members of the Bocavirus, Picobirnavirus and Cosavirus genera and of the family 
Anelloviridae that are potential human pathogens, as well as novel viruses that may be 
??????????? ????? ??????? ?????? ????? ????????????? ???????????????Nodaviridae, 
Dicistroviridae, Virgaviridae and Partitiviridae??????? ???? ?????????? ??????????????????
eukaryotic DNA viruses in metagenomic data sets has led to a new perspective on the 
potential importance and diversity of these small viruses138. Although these viruses 
were initially identified in symptomatic individuals, they have also been identified, at a 
similar prevalence, in asymptomatic contacts of individuals with disease. The broad 
representation of these eukaryotic viruses in the human gut as well as in other body 
habitats has prompted a call to consider the functional significance of the human 
eukaryotic virome12. The almost ubiquitous presence of human viruses that are not 
phages and have not been associated with any disease indicates that viruses, especially 
those acquired in early childhood, might be essential for proper immune system 
development and that particular host genotypes or immunological constraints might 
cause normally benign viruses to induce disease states.
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member of a community, lysogenic phages could be 
introduced to promote a community structure that is 
beneficial to both the human host and microbial commu-
nity members (FIG. 3). For example, we could expand the 
capacity of the gut microbiome to degrade dietary com-
ponents99. Similarly, phages could be used to introduce 
novel, beneficial traits to community members, such as 
those involving nutrient biosynthesis. In these cases, it 
may be difficult to introduce traits that are not purely 
beneficial to the bacterial host of a lysogenic phage, as the 
energetic effects of synthesizing an unnecessary protein 
may impose a selection pressure.
Given the potential power and replicative nature of 
phages, a number of questions must be addressed before 
these viruses can be more widely adopted as therapeutics, 
including issues related to biocontainment98. Although 
phages are frequently sold as viruses that ‘can only infect 
bacteria’, their safety has yet to be completely defined. 
The intravenous administration of phages (for example, 
in the case of bacterial sepsis) is particularly complex 
Figure 3 | Potential strategies for phage therapy. a?|?The traditional strategy for phage therapy has been to use a lytic 
phage that targets pathogenic bacteria. Although this approach is transiently useful, it can lead to rapid bacterial 
resistance owing the resultant positive selection for subpopulations (clones) that are resistant to the lytic phage. Note 
that this is an antiquated approach to phage therapy and can be trivially improved by using multiple phages with 
non-overlapping host resistance patterns or by selecting for phage mutants that overcome host resistance. b?|?More 
recently, the synergistic relationships between phages and antibiotics have been exploited, with the use of lysogenic 
phages that do not kill the pathogen when used alone but instead decrease its survival when used in concert with 
antibiotics. An example is a phage that inhibits a DNA damage repair system (the SOS response), thus rendering the host 
bacterium exquisitely sensitive to quinolone class antibiotics140. c?|?With our growing understanding of the human 
microbiome, it may be possible to take a more nuanced approach, selectively manipulating (that is, enhancing) microbial 
community functions or clearing the way for invasion by probiotic consortia. Strategies can be envisioned that benefit 
both microorganisms and their hosts; for example, introducing into phage genomes certain genes that are involved in 
nutrient biosynthesis (with direct benefits to the bacterial, and potentially also the human, host) or degradation 
(potentially stabilizing the abundance and niches of beneficial microorganisms, especially during times of acute stress).
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given the immunogenicity of some preparations and the 
rapid clearance of phage particles by the reticuloendothe-
lial system of the spleen100. It is tempting to assume that 
other routes of administration, such as oral cocktails of 
phages to target the human gut micro biome, would not 
have such effects; however, phage DNA is detectable by 
PCR and FISH (fluorescence in situ hybridization) in the 
serum shortly after oral consumption of phages101. Other 
studies have provided evidence of trans-placental passage 
of phages102. There are data suggesting that enzymes tran-
scribed from phage DNA can be expressed in mamma-
lian cells103; this finding has even led to attempts to use 
phages as gene therapy vectors104,105.
Despite these concerns, we are exposed to millions of 
phages every day, including those from our own micro-
biota, without significant observable harm. Given this 
fact, it is interesting to consider the potential thera-
peutic use of phages in the context of current efforts to 
apply microbiome-directed therapies106. Questions that 
can be asked include whether it is beneficial or detri-
mental for candidate probiotic bacterial taxa to possess 
or lack prophages, or whether phages should be delib-
erately administered coincidently with or preceding the 
introduction of a probiotic consortium in order to help 
create a niche that promotes successful invasion and 
engraftment of the consortium.
Future directions
Little experimental work has been carried out on the 
ecology of phages in vivo. Germ-free mice and mice 
monocolonized with different strains of Escherichia 
coli, including strains that were isolated from children 
with diarrhoea, have been used to examine the replica-
tion of T4 and T7 phages107,108. Models of the human 
gut microbiota using gnotobiotic mice may not only 
provide a better understanding of phage–bacterial host 
dynamics, but also represent a potentially valuable tool 
for establishing a preclinical pipeline designed to evalu-
ate the feasibility of phage therapy. Recent work has 
shown that transplanting intact, uncultured human gut 
microbial communities (in the form of a faecal trans-
plant) into gnotobiotic mice is efficient, and captures 
the majority of the microbial diversity and microbiome-
encoded functions that are present in the human donor’s 
community109,110. Mice with replicated human gut micro-
biomes can be fed diets resembling those of the human 
donor to explore diet–microbiome–phage interactions. 
An additional refinement to this approach is to culture 
and sequence collections of bacteria (some members of 
which will contain prophages) from a given donor’s fae-
cal sample and transplant these collections into recipi-
ent mice110. Various perturbations can be applied to the 
gnotobiotic mice harbouring these microbiota (such 
as changes in diet or manipulation of the immune sys-
tem), and the effects of these perturbations on phage–
bacterium dynamics can be studied over time under 
highly controlled conditions.
Yet another envisioned approach is to take cultured, 
sequenced members of the human gut microbiota and 
use these to assemble defined communities in formerly 
germ-free mice. Preparing VLPs from human faecal 
samples and introducing them into these mice would 
allow investigators to directly determine the bacterial-
host specificity of VLP-associated phages. This approach 
could also allow researchers to assess the effects of the 
presence or absence of a prophage in community mem-
bers, the effects of the diet administered to the animals 
and the contribution of phages to mammalian host 
physiology, including immune function. The impact of 
a staged phage attack on community structure and func-
tions can also be defined in gnotobiotic animal mod-
els over time and as a function of location within the 
length of the gut, where the available nutrient and energy 
resources vary considerably.
These model systems should help us understand how 
phages influence metabolism in the gut and how we can 
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